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ABSTRACT 
Children diagnosed with sickle cell disease (SCD) struggle with executive functions (EF); 
however, there is a paucity of research on neuropsychological outcomes in adults with SCD. This 
study aimed to examine differences in EF between adults with SCD and healthy controls. Thirty-
one patients with SCD and 34 healthy controls (ages 18-45) participating in an IRB-approved 
Children’s Hospital Los Angeles (CHLA) study of cerebral blood flow underwent 
neuropsychological evaluation using the Delis–Kaplan Executive Function System (D-KEFS) 
Trail Making and Color Word Interference Tests and the Wechsler Adult Intelligence Scale - 
Fourth Edition (WAIS-IV) Digit Span subtest to assess various aspects of EF. The Wechsler 
Abbreviated Scale of Intelligence - Second Edition (WASI-II) was administered to estimate 
general intellectual ability. There were no significant differences between groups related to age, 
gender, race, parental education, or general intellectual ability; however, the control group was 
estimated to have significantly higher current combined annual family income as compared to 
patients with SCD, x2 (6, N = 65) = 10.87, p = .02. Therefore, income was statistically controlled 
for during analyses. Both groups performed in the solidly average range across EF measures and 
no significant differences were noted between groups in working memory, F(1) = .009, p = .93, 
ηp2 = .000; inhibition, F(1) = .156, p = .03, ηp2 = .03; or cognitive flexibility, F(1) = 3.11, p = 
.08, ηp2 = .06. Adults with SCD in this study performed comparably to healthy controls. Early 
treatment with hydroxyurea to the maximum tolerated dose may improve prognosis and serve as 
a protective factor against EF deficits in adults with SCD. However, additional research is 
needed to better understand how treatment protocols influence neuropsychological outcomes in 
this population.
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Chapter 1: Statement of the Problem 
Sickle cell disease (SCD) refers to a group of inherited disorders characterized by two 
sickle cell genes (one gene is required from each parent) in which misshapen blood cells lead to 
anemia among other complications (National Heart, Lung, and Blood Institute [NHLBI], n.d.). 
These disorders result in a range of complications including episodes of intense pain, stroke, 
susceptibility to infection, academic challenges, and changes in cognitive functioning (Centers 
for Disease Control and Prevention [CDC], 2016; Manci et al., 2003).  
SCD most commonly affects individuals of African ancestry (e.g., African American, 
Afro-Caribbean); however, there is also occurrence in individuals of Mediterranean, Middle 
Eastern, Asian Indian, and South or Central American descent (Brousseau, Panepinto, Nimmer, 
& Hoffmann, 2010; Hassell, 2010; Nelson & Hackman, 2013; Quinn, Rogers, McCavit, & 
Buchanan, 2010; Rees, Williams, & Gladwin, 2010; Yanni, Grosse, Yang, & Olney, 2009). In 
the United States (U.S.), approximately 1 in 365 African American children (approximately 8%) 
are diagnosed with SCD as compared to the next most common community, which is 1 in 16,305 
Latinos (approximately 0.00006%; Hassell, 2010; Huttle, Maestre, Lantigua, & Green, 2015; 
NHLBI, n.d.). The descendants of those most commonly affected hail from regions with a 
relatively recent history of pervasive malaria infection (Aidoo et al., 2002; Allison, 1954; Gilles 
et al., 1967). The single sickle cell gene has served an adaptive function in these populations, as 
it protects those with sickle cell trait (SCT; i.e., one sickle gene as opposed to two) against death 
from malaria. The malaria parasite lives in the red blood cells of its host; however, due to 
premature hemolysis (i.e., breakdown) of sickled red blood cells, the parasite is unable to 
reproduce (Wiesenfeld, 1967). This clearly provides a distinct advantage for those individuals 
who face potential death due to malaria exposure, although in areas where the disease is rare, 
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sickled red blood cells provide no benefits to survival for the population as a whole. Unlike their 
SCT counterparts, those with SCD are generally more susceptible to infection (Platt et al., 1994).  
Due to the slave trade’s strong tie to our nation’s history, there exists a significant 
population of African Americans in the United States (U.S.). Unfortunately, their health and 
prosperity have not been an area of great focus since the abolition of slavery (Phillips, 1999) and 
African Americans have faced alarming health disparities in this nation (CDC, 2005; Landrine & 
Corral, 2009; Orsi, Margellos-Anast, & Whitman, 2010). During the 1960s and ‘70s, the sickle 
cell cause became a focus within the civil rights movement with activists citing the reality that 
most patients with SCD did not live beyond their teenage years (Scott & Castro, 1979; Wailoo, 
2014). In response to calls for action, the Sickle Cell Anemia Control Act was passed into law in 
1972 which allocated federal funding for the research, education, screening, and treatment of 
SCD.  
At the time of the Sickle Cell Anemia Control Act, the majority of SCD-related deaths 
occurred in early childhood, leading the disease to be considered a pediatric condition (Gill et al., 
1995; Lee, Thomas, Cupidore, Serjeant, & Serjeant, 1995). However, in the 1990s, the average 
life expectancy for individuals with SCD jumped to the 40s (Platt et al., 1994). This is 
attributable to newborn infant screening programs (i.e., state-mandated targeted genetic testing 
for all newborns) which began to include SCD in the 1960s and ‘70s, the use of prophylactic 
antibiotics and vaccinations, as well as the rise of treatments such as blood transfusion and 
hydroxyurea (Chaturvedi & DeBaun, 2016; El-Haj & Hoppe, 2018; Gaston et al., 1986; Lopes de 
Castro Lobo et al., 2013; Yanni et al., 2009). As patients with SCD are beginning to live much 
longer than they have in the past, it is increasingly important to understand the disease in adult 
populations. Lanzkron, Carroll, and Haywood (2013) found that the adult mortality rate 
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increased by 1% annually between 1979 to 2005, while the pediatric mortality rate decreased by 
3% annually during the same time period (both p < 0.001). While these patterns in mortality may 
be reflective of an increase in life expectancy in SCD patients, the investigators note that it is 
likely that this at least partially reflects a lack of access to comprehensive adult care. Further, 
young adults transitioning from pediatric to adult care are at the highest risk for death (Quinn et 
al., 2010), many of which are related to acute medical events which suggests that these 
individuals may have not been able to sufficiently establish connections with adult specialists. 
This has occurred alongside a relative increase in research and comprehensive care in pediatric 
SCD when compared to adults (Grosse et al., 2011). This disparity in adult SCD care may be 
ameliorated following an increase in research focused on the needs of patients as they transition 
from pediatric to adult care.  
In addition to medical research, increased life expectancy necessitates a better 
understanding of the neuropsychological impact of SCD in adults. A growing body of literature 
has contributed to our understanding of the neuropsychological effects of SCD in the pediatric 
population, particularly related to executive functions (EF) which are higher order cognitive 
skills necessary for mental planning, organization, and execution/completion of purposeful, goal-
oriented tasks. However, a relative paucity exists when considering the effects in adults. This 
study aims to inform a greater understanding of the effect of SCD on EFs in the adult population. 
More specifically, the study will determine whether previous research demonstrating decreased 
performance among children with SCD will be replicated within an adult SCD sample.  
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Chapter 2: Review of the Literature 
Sickle Cell Disease (SCD) refers to a group of inherited red blood cell disorders whose 
primary physical feature is abnormally shaped hemoglobin - a protein that carries oxygen 
through the body via red blood cells (Howard & Telfer, 2015; Ilesanmi, 2010; Kral, Brown, & 
Hynd, 2001; NHLBI, n.d.). Typical hemoglobin in adults is known as hemoglobin A (HbA). The 
disc shape of HbA allows the cells to easily move through blood vessels without sticking to 
vessel walls or becoming obstructed. Sickle hemoglobin, known as hemoglobin S (HbS), is 
shaped like a crescent, or sickle, as the name implies. This results in cells that stick to vessel 
walls, particularly fine capillaries and arterioles, causing partial or complete obstruction, and 
impaired delivery of oxygen throughout the body. Over time, sickled blood cells cause 
irreversible damage to blood vessel membranes as they attempt to squeeze through the small 
passageways, which leads to dehydration of the cells.  
Genotypes 
As SCD refers to a group of disorders, there are various genotypes through which the 
disease can be manifested (Kral et al., 2001). The most common and severe genotype of SCD is 
hemoglobin SS (HbSS) which is also known as sickle cell anemia1 (SCA). Other forms of SCD 
also have their names derived from the type of hemoglobin inherited (e.g., HbSC, HbSD, HbSE; 
CDC, 2016). The complications typical of each genotype vary in quality and severity. As of 
2006, all states within the U.S., including Puerto Rico and the U.S. Virgin Islands, mandate 
HbSS testing as part of the standard newborn screening tests (Benson & Therrell, 2010). This 
early screening allows prompt diagnosis and subsequent medical care at 
 
1 Some practitioners also include the genotype Sβ0-thalassemia (HbSβ0-thalassemia) in SCA as 
the subtypes present similarly (NHLBI, 2014).  
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specialized treatment centers where available (Raphael, Kavanagh, Wang, Mueller, &  
Zuckerman, 2011). Screening is particularly important as infants with SCD typically do not 
initially show signs of the disease due to the protective nature of fetal hemoglobin (HbF), which 
is in dominant production until approximately 6 months of age (Edoh, Antwi-Bosaiko, & 
Amuzu, 2006; Watson, Stahman, & Bilello, 1948). While adults retain the capacity to produce 
HbF, levels of production drop to less than 1% by age 2, which is below clinical significance 
(Mosca, Paleari, Ivaldi, Galanello, & Giordano, 2009, Thein & Menzel, 2009). There is evidence 
to suggest that in some cases, elevated levels of HbF continue to be produced into adulthood, 
which assists in managing pain crises (Edoh et al., 2006; Gardner & Thein, 2016); however, this 
only occurs in approximately 10% of the general population (Thein & Craig, 1998; Thein & 
Menzel, 2009). 
In addition to the aforementioned SCD genotypes, there are also individuals with Sickle 
Cell Trait (SCT). In order to acquire SCD, a child must receive two genes for SCD – one from 
each parent (CDC, 2016). However, individuals with SCT received only one of these genes, and 
as a result, they are carriers for the disorder although they do not experience the full range of 
symptoms. Despite this, there are rare, yet serious complications that may occur even with SCT. 
These include blockages in small blood vessels in very low oxygen conditions (e.g., high 
altitude, physical exertion), increased susceptibility to infection, kidney cancer, and reduced 
blood flow to the spleen (American Society of Hematology, n.d.; Eichner, 2007; Thogmartin et 
al., 2011; Yanamandra, Das, Malhotra, & Varma, 2018). As SCD is an autosomal recessive 
condition, individuals with SCT may also pass SCD along to their children if that child receives 
one sickle cell gene from each parent.  
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Medical Complications 
The primary function of hemoglobin is to transport oxygen to organs throughout the body 
(Kral et al., 2001). One of the most common complications of SCD is poorly oxygenated tissue 
(i.e., hypoxia) due to the misshapen, inefficient hemoglobin S, which results in vaso-occlusive 
crises (also known as VOCs, pain crises, and acute painful episodes; NHLBI, n.d.; Serjeant & 
Serjeant, 1992). This mild to extremely severe pain is caused when blood flow is disrupted in 
small blood vessels (CDC, 2016). The pain may be described as throbbing, sharp, or gnawing 
(Rees et al., 2003). These episodes are the most frequent reason for emergency room visits for 
patients with SCD (CDC, 2016). Additionally, sickled blood cells last only 10 to 20 days as 
compared to 90 to 120 days for normal cells, requiring increased speed in replenishment. The 
body has difficulty keeping up with the production of new red blood cells, leading to anemia, 
which may be manifested as lethargy, slowed growth, or delayed puberty. Other common 
complications of SCD include hand-foot syndrome (i.e., swelling in the hands and feet as a result 
of sickled blood cells obstructing blood flow in the extremities), increased risk for infection, 
acute chest syndrome (i.e., life-threatening chest pain, coughing, difficulty breathing, and fever), 
splenic sequestration (i.e., life-threatening enlargement of the spleen), ischemic priapism (i.e., 
painful, prolonged erections), vision loss, and increased risk for blood clots. Over time, 
significant damage can occur to body organs, tissues, and/or bones due to insufficient blood 
flow. Infection, heart disease, stroke, and liver disease are leading causes of death in the SCD 
population (Lanzkron et al., 2013). Despite increased understanding of the disease processes 
involved with SCD as well as revised treatment recommendations, recent research suggests the 
rate of SCD related complications has risen which may be attributable to improved survivorship 
(Perumbeti et al., 2018).  
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Neurological complications of SCD include symptomatic infarction (i.e., arterial 
obstruction in the brain which impairs blood/oxygen flow and is accompanied by traditional 
neurologic symptoms; also known as overt stroke or cerebrovascular accident [CVA]) and 
intracranial hemorrhage (i.e., rupture of a blood vessel in the brain; Thust, Burke, & Siddiqui, 
2014). These are serious complications, which affect approximately 24% of SCA patients by age 
45 (Ohene-Frempong et al., 1998). The risk remains significant in the broader SCD population 
(as compared to SCA specifically), with approximately 10% of individuals experiencing overt 
stroke in their lifetime (Farooq & Testai, 2019). Unlike their SCD counterparts, a recent meta-
analysis found that African Americans with SCT are not at increased risk for ischemic stroke 
(Hyacinth et al., 2018). 
Transcranial doppler (TCD) can be utilized to measure blood flow velocity. Overall, 
those with an elevated TCD in the absence of blood transfusion are at the highest risk for initial 
overt stroke although this risk can be reduced with the timely initiation of chronic blood 
transfusions (Adams & Brambilla, 2005). It is recommended that TCD be utilized routinely in 
SCD care (every 6 to 12 months) beginning at 24 months of age (Adams, 2005). Despite these 
recommendations, one single-site study indicated that only 43% of board-certified pediatric 
hematologists complied with this guideline (Raphael, Shetty, Liu, Mahoney, & Mueller, 2008). 
The same researchers also found that patients with private insurance were three times more likely 
to keep scheduled TCD appointments when compared to those with public insurance. 
While strokes are often manifested by overt neurological symptoms such as numbness, 
weakness, confusion, visual changes, or severe headache (National Center for Chronic Disease 
Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, 2017), 
individuals with SCD are also at an increased risk for silent stroke (also known as silent cerebral 
 8 
infarct; SCI). In such instances, patients do not experience overt neurological symptoms; 
however, abnormalities are noted on magnetic resonance imaging (MRI; Kinney et al., 1999). On 
MRI, SCI are typically visible as white matter hyperintensities (WMHs; van der Land, et al., 
2016). Although small WMHs are sometimes seen in healthy populations (Debette & Markus, 
2010; Hopkins et al., 2006; Sachdev, Chen & Wen, 2008), the quantity and volume are often 
exceptional in those with SCD, with the prevalence as high as 39.1% by age 18 (DeBaun et al., 
2012; Farooq & Testai, 2019; Wang et al., 2001). In both children and adults, SCI increases the 
patient’s risk for subsequent SCI and/or overt stroke (Jordan et al., 2018; Pegelow et al., 2002).  
Overt strokes tend to occur in the internal carotid and middle cerebral arteries in patients 
with SCD (Adams et al., 1988; Pavlakis et al., 1988; Pegelow et al., 2002; Rothman, Fulling, & 
Nelson, 1986; Schatz, Brown, Pascual, Hsu, & DeBaun, 2001; Switzer et al., 2006; Telfer et al., 
2011; Wang et al., 1998; Waterston, Brown, Butler, & Swash, 1990). Overall, the regions of the 
brain distally served by the anterior and middle cerebral arteries (known as the border zones due 
to decreased perfusion in these relatively distant areas; Mangla, Kolar, Almast, & Ekholm, 2011) 
are the most commonly affected, including the deep white matter, basal ganglia, middle and 
superior frontal gyrus, and dorsal parietal regions (Pavlakis et al., 1988; Powars et al., 1999). SCI 
in the border zones are associated with low velocity blood flow, suggesting insufficient 
oxygenation to the affected tissue (Ford et al., 2018). In the SCD population, infarct in the frontal 
lobe is the most frequently affected location, found in up to 93% of patients with either silent or 
overt stroke (Brown et al., 2000; Schatz et al., 2001). To date, literature has not examined 
differences in stroke location in adults as compared to children; however, adults are more likely 
to have a broader etiology which may include fat embolism or illicit substance use (Calvet et al, 
2015). Collectively, overt strokes account for approximately 10% of all SCD deaths (Manci et 
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al., 2003). Even without evidence of tissue damage, chronic cerebral blood flow dysfunction has 
also been noted in adult SCD patients (Doepp, Kebelmann-Betzing, Kivi, & Schreiber, 2012).  
Medical Treatments 
Treatments for SCD include pain management, red blood cell transfusion, hydroxyurea, 
Endari, and stem cell transplantation (also known as bone marrow transplant; Mayo Clinic Staff, 
2019).  Each of these treatments are discussed in greater detail below. 
Pain management. As mentioned, one of the most common complications of SCD are 
acute painful episodes which tend to become more frequent with age (Panepinto, Brousseau, 
Hillery, & Scott, 2005). Similarly, adults with SCD tend to have higher rates of emergency room 
visits when compared to pediatric samples (Wolfson, Schrager, Khanna, Coates, & Kipke, 2012). 
The episodes are so common that the American Pain Society, American College of Physicians, 
NHLBI, and the CDC’s National Center on Birth Defects and Developmental Disabilities have 
each published guidelines for the use of analgesics with the SCD population. They all indicate 
that SCD requires prompt treatment and recommend the use of opioids for severe pain. The use 
of oral morphine has even been found to decrease the rate of hospitalization as well as the need 
for intravenous medication (Paquin et al., 2019). In addition to these acute VOCs, many adults 
with SCD also experience daily chronic pain (Smith et al., 2008). Alternatives to pharmacology 
are available and effective to lessen SCD-related chronic pain. Interventions include prayer or 
spiritual healing, acupuncture, massage therapy, meditation, self-hypnosis, relaxation training, 
and cognitive behavioral therapy (Anie & Green, 2015; Chen, Cole, & Kato, 2004; Dinges et al., 
1997; Sibinga, Shindell, Casella, Duggan, & Wilson, 2006; Thomas, Dixon, Milligan, & 
Thomas, 1999; Thomas, Wilson‐Barnett, & Goodhart, 1998; Williams & Tanabe, 2016). 
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Transfusions. Red blood cell transfusion increases the number of circulating red bloods 
cells by removing them from donor blood and transferring them to the recipient intravenously. 
The benefits of red blood cell transfusion include temporary correction of anemia, improvement 
of the blood’s ability to transport oxygen, reduction or prevention of sickling, and control or 
prevention of vascular and tissue damage (Howard & Telfer, 2015). Blood transfusion also 
reduces the risk of overt stroke; however, possible complications include infection and iron 
overload, among others (Ballas, 2001; Ballas, Zeidan, Duong, DeVeaux, & Heeney, 2018; 
DeBaun et al., 2014; Garraud et al., 2018; Harmatz et al., 2000; Talahma, Strbian, Sundararajan, 
2014; Verduzco & Nathan, 2009). Chronic blood transfusions, every three to four weeks, are 
common for those with elevated TCD which indicates a high risk for overt stroke. Excessive iron 
in the blood may be controlled through chelation therapy (i.e., the removal of iron from the body 
with the use of medication such as Jadenu; Allali, de Montalembert, Brousse, Chalumeau, & 
Karim, 2017; Cohen & Martin, 2001; Kwiatkowski & Cohen, 2004).  
Hydroxyurea. Hydroxyurea is an enteral chemotherapy medication which reduces the 
occurrence of pain crises, acute chest syndrome, and the need for blood transfusions in patients 
with SCD primarily by stimulating the production of HbF (Lanzkron, Rand, Haywood & Hassell, 
2008; Voskaridou et al., 2010; Wong, Brandow, Lim, & Lottenberg, 2014). Higher rates of HbF 
predict increased life expectancy in patients with SCA (Platt et al., 1994; Powars, Weiss, Chan, 
& Schroeder, 1984; Voskaridou et al., 2010; Wong et al., 2014) and at least one study has 
demonstrated improvement in survival associated with duration of hydroxyurea exposure 
(Voskaridou et al., 2010). In 2002, the NHLBI issued seminal guidelines encouraging the use of 
hydroxyurea for those with SCD. Despite these benefits and guidelines, a survey of adult SCD 
providers indicated that the drug was prescribed for less than half of eligible patients (Lanzkron 
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et al., 2008). This survey also indicated significant group differences with regard to provider 
race, as providers who identified as Black had higher rates of eligible patients on hydroxyurea 
than those identifying as White (94% vs 73%). The most frequent reasons endorsed by providers 
for not prescribing the medication was related to lack of awareness of the drug and disagreement 
regarding the benefits. Even when prescribed, adherence is often poor, which may be related to 
delayed onset of symptoms following a missed dose as well as fear of long-term toxicity 
(Brandow & Panepinto, 2010; Heeney & Ware, 2010). Current NHLBI (2014) guidelines include 
the introduction of hydroxyurea as early as 9 months of age and continued use throughout the 
lifespan regardless of clinical severity.  
Endari. In 2017, the U.S. Food & Drug Administration (FDA) announced that a new 
drug, Endari, was approved to treat the complications of SCD in patients age five years and 
older. The generic agent is L-glutamine and while the drug’s mechanism of action is not 
completely understood, it is believed to reduce oxidative damage to red blood cells (Niihara et 
al., 2018). The treatment lowered the incidence of both pain crises and acute chest syndrome in a 
clinical sample and decreased the number of hospitalization days (p = 0.005). Although there is 
some additive benefit when used in conjunction with hydroxyurea, Endari comes at a much 
higher cost than its predecessor (approximately $40,515 annually as compared to $1,700; The 
Medical Letter, Inc., 2018). This is only the second drug approved for the treatment of SCD and 
the first new treatment in almost 20 years.  
Stem cell transplant. Stem cell transplants are the only potential cure for SCD and 
involve intravenously replacing bone marrow in the recipient with healthy donor bone marrow 
(NHLBI, n.d.). As part of the treatment, the recipient also receives chemotherapy and/or 
radiation to destroy their own stem cells so that the donor cells may proliferate. It is difficult to 
 12 
find an appropriate donor and the potential complications are serious, including graft-versus-host 
-disease (a complication in which the donor tissue begins to attack the host tissue) and even 
death. As these risks are increased with older age, transplants are reserved for individuals 
younger than 16 years old with particularly problematic symptoms. For these reasons, treatment 
for SCD typically focuses on avoiding pain crises, symptom management, and prevention of 
complications. 
Neuropsychological Effects 
In addition to the aforementioned physical symptoms, a range of neuropsychological 
impairments have also been identified, even in individuals without a history of stroke (Wang et 
al., 2001). Given the historically shortened lifespan in SCD, the literature has primarily focused 
on pediatrics and limited research is available with adult participants. Therefore, the following 
review will focus on the pediatric literature with a briefer discussion on the available adult 
literature. Prior research has generally identified deficits in the following domains: cognition, 
processing speed, learning and memory, academic achievement, visual motor integration, 
attention, and EFs. The current literature review places a particular emphasis on EFs, which are 
the primary area of consideration in this study. 
Cognition. In the most commonly used measures of intellectual functioning, the Full 
Scale Intelligence Quotient (FSIQ) is a composite score based on performance on multiple tasks 
which measure various subskills (typically inclusive of verbal and nonverbal reasoning, 
processing speed, and working memory)2. Due to the integration of these subskills into a single 
 
2 Relevant findings related to processing speed and working memory, along with other aspects of 
neuropsychological functioning, are discussed further in the subsequent sections. 
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estimate of intellectual functioning (i.e., FSIQ), impaired performance in any of these areas will 
reduce the broader FSIQ.  
IQ testing has commonly been used as an overall measure of cognition in SCD research 
and children with SCA have historically demonstrated significantly lower IQ scores when 
compared to healthy controls (Armstrong et al., 1996; Brown, Armstrong, & Eckman, 1993; 
Schatz et al., 2001; Schatz, Finke, Kellett, & Kramer, 2002). Children with SCA and history of 
overt stroke demonstrated the greatest level of impairment, followed by children with history of 
SCI, and then by children with no history of stroke (Cohen, Branch, McKie, & Adams, 1994; 
DeBaun et al., 2012; Hogan, Pit-ten, Vargha-Khadem, Prengler, & Kirkham, 2006). Performance 
on measures of IQ is negatively correlated with volume of WMHs (Schatz et al., 2002); however, 
even in the absence of stroke, children with SCA continue to perform significantly below healthy 
race, age, sex, and education matched controls (Berkelhammer et al., 2007; Kawadler, Clayden, 
Clark, & Kirkham, 2016; Schatz et al., 2002), which is likely attributable to their chronic 
hypoxic state as discussed above (Armstrong, Pavlakis, Goldman, Thompson, & Cuadra, 2010; 
Kawadler et al., 2015). Further, the progression of WMHs was related to general cognitive 
decline. Taken together, these results suggest that neuroanatomical changes in individuals with 
SCD contribute to neuropsychological functioning. 
Although the number of studies with adult patients is far smaller than those in pediatrics, 
there is also evidence to suggest poorer general intellectual functioning in adults with SCA 
regardless of history of stroke (Kugler et al., 1993). Vichinsky and colleagues (2010) conducted 
the only large-scale study examining general cognitive functioning in adults with SCA. They 
found that the mean FSIQ for patients with SCA was 90.47, as compared to 95.66 for age, sex, 
and education matched healthy controls (p = .008). This reflects a difference of approximately 5 
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IQ points, or 1/3 standard deviation, although some of these differences may be due to slower 
processing speed (Crawford & Jonassaint, 2016). Mackin and colleagues (2014) utilized data 
from Vichinsky’s research to examine the relationship between neuropsychological functioning 
and frontal lobe cortical thickness and basal ganglia volumes. They found that participants with 
SCA had thinner frontal lobe cortex as well as reduced basal ganglia and thalamus volumes 
when compared to healthy controls. As a result, they adjusted data from Vichinsky et al., (2010) 
for intracranial volume and found significant differences between those with SCA and healthy 
controls based on Wechsler Adult Intelligence Scale – Third Edition (WAIS-III) FSIQ after 
controlling for age, sex, and education level (adjusted mean, standard score of 91.2 for patients 
vs 96.0 for controls [mean difference, −4.8]; p = .04). Lower IQ in the SCD population is also 
consistent with findings of a meta-analysis which found that insults to white matter (which are 
comprised of myelinated axons that facilitate quick communication between neurons) are 
inversely associated with general cognitive functioning in non-SCD adult populations (Debette 
& Markus, 2010; Vasquez & Zakzanis, 2015). 
Processing speed. Processing speed refers to the time it takes to perceive and respond to 
a stimulus or demand.  Most processing speed tasks used in the SCD literature have utilized 
psychomotor processing speed in particular (e.g., quickly matching numbers with symbols or 
quickly scanning/marking complex arrays for specified targets). Some tests of processing speed 
also measure accuracy by deducting points for errors. Overall, children with SCD tend to 
demonstrate slower processing speed when compared to a normative population, with those with 
SCA demonstrating the greatest impairment as compared to both SCD and healthy samples 
(Smith & Schatz, 2016). Armstrong et al. (1996) also found significant differences on the 
Wechsler Intelligence Scale for Children – Revised (WISC-R) Coding subtest (Wechsler, 1974; 
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i.e., a measure that requires children to quickly pair numbers with geometric figures) when 
comparing pediatric SCD patients with history of overt (p = .003) and silent stroke (p = .01), to 
those with normal MRI. Van der land et al. (2016) found that higher volume of WMHs in 
pediatric SCD patients was associated with reduced processing speed (as well as lower FSIQ; 
however, as discussed, processing speed is a component of FSIQ).  
With regard to research on processing speed in adults, Vichinsky et al. (2010) and 
Crawford and Jonassaint (2016) both reported significantly lower (approximately 2/3 standard 
deviation) processing speed in adults with SCA without history of CVA when compared to age, 
sex, and education matched healthy controls - 11.46 (p < .001) and 10.77 (p = 0.02) points 
respectively.3 This reflects the largest area of significant group difference (adjusted mean 
standard score of 86.5 for patients vs 97.9 for controls [mean difference, -11.4]; p < .001; 
Vichinsky et al., 2010). Again, when Mackin et al. (2014) adjusted data from Vichinsky et al. 
(2010) for intracranial volume, results also documented significantly lower processing speed in a 
patient sample when compared to healthy controls (adjusted mean, standard score of 87.2 for 
patients vs 95.4 for controls [mean difference, −8.2]; p < .001). When these clinically and 
statistically significant differences are accounted for, individuals with SCD see improved 
performance in FSIQ scores, 3 points higher than those same controls (Crawford & Jonassaint, 
2016; Stotesbury et al., 2018). Further, Vichinsky et al. (2010) did not find significant group 
differences with regard to verbal (adjusted mean standard score of 92.14 for patients vs 96.04 for 
controls [mean difference, -3.90]; p = .06) or nonverbal reasoning (adjusted mean standard score 
 
3 Vichinsky et al. (2010) utilized a sample of SCA patients whereas Crawford and Jonassaint 
(2016) utilized a more general sample of SCD patients. It should also be noted that different 
measures were utilized to obtain these scores, Wechsler Adult Intelligence Scale – Third Edition 
(WAIS-III) and CNS Vital Signs scores, respectively. 
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of 90.75 for patients vs 95.10 for controls [mean difference, -3.96]; p = .06). These results 
corroborate deficits in processing speed performance in adults with SCD, while suggesting that 
lower FSIQ scores are best accounted for by slower processing speed. Jorgensen and colleagues 
(2017) also published a study evaluating processing speed in an adult population. Participants 
with genotypes typically associated with the most severe complications (e.g., HbSS) obtained a 
mean T-score of 47.6 (SD = 14.5) on a measure of processing speed as compared to those with 
moderate complications (e.g., HbSC), who obtained a mean T-score of 51.0 (SD = 13.4; both p = 
.004). Again, this is consistent with findings of a meta-analysis of a general adult population 
which found that WMHs are inversely associated with performance on measures of processing 
speed (Debette & Markus, 2010); and that insult to subcortical white matter tracts is associated 
with slower processing speed (Vasquez & Zakzanis, 2015). These differences in processing 
speed have important implications for other aspects of neuropsychological functioning such as 
academic achievement, EF, adaptive behaviors, as well as learning and memory.  
Learning and memory. In simplest terms, learning and memory refers to the ability to 
acquire and recall new information. The neuroanatomy of memory is complex and involves 
various structures; however, memory involves two primary circuits. The first is the Papez circuit 
(also known as the medial limbic circuit) which has been implicated in autobiographical and 
explicit memory (Bauer, 2008; Preston & Eichenbaum, 2013; Schoenberg & Scott, 2011; Stucky, 
Kirkwood, & Donders, 2014). The hippocampus is a central structure (where the circuit begins 
and ends) that acts in coordination with the mammillary bodies, anterior thalamic nuclei, and 
cingulate gyrus (Catani, Dell’Acqua & de Schotten, 2013). A second circuit, the lateral limbic 
circuit, utilizes the amygdala as the central structure and has been implicated in emotional 
memory and assigning emotional significance to stimuli. The lateral limbic circuit acts in 
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coordination with the dorsomedial nucleus of the thalamus, orbitofrontal cortex, and uncinate 
fasciculus (Stucky et al., 2014). Damage to either structure can result in memory impairment; 
however, if damaged, each of these systems can accommodate one another to a large extent. In 
addition, the dorsolateral prefrontal cortex (PFC) plays a role in memory consolidation and 
organization while the cerebellum contributes to nondeclarative (also known as implicit) 
memory (Preston & Eichenbaum, 2013; Schoenberg & Scott, 2011).  
Deficits in learning and memory have been noted in the pediatric SCD population. On a 
measure of rote verbal list learning, children with diffuse cerebral infarcts retained 
approximately 20% less information than their healthy sibling controls despite several repetitions 
(Schatz et al., 1999). Brandling-Bennett, White, Armstrong, Christ, and DeBaun (2003) found 
similar challenges in list learning, while Watkins et al. (1998) noted significant group differences 
on measures of visual memory and paired associate learning when children with SCD and a 
history of frontal lobe infarct (either SCI or CVA) where compared to children with SCD 
without stroke history and healthy controls.  
Conversely, impairments in learning and memory have not been documented in 
neurologically asymptomatic adults with SCA as compared to healthy demographically matched 
controls (Vichinsky et al., 2010); however, this domain is understudied and only relatively 
recently evaluated. Further, studies examining functioning in a more general SCD population 
were not available. As such, continued research is necessary. 
Academic achievement. Children with SCD face academic challenges and are more 
likely to be retained (i.e., held back to repeat a grade), receive special education services, and 
have a higher rate of absences when compared to peers (Dyson, Atkin, Culley, & Dyson, 2007; 
Epping et al., 2013; Schatz, 2004). Fatigue and medical complications (e.g., infection, pain 
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episodes) may account for at least a portion of these absences and subsequent loss of instruction 
time. Learning difficulties in children with SCD include deficits in reading and mathematics 
(Brown et al., 1993; Schatz et al., 2001). More specifically, left hemispheric overt stroke has 
been associated with more global academic delays while those in the right hemisphere have a 
stronger association with deficits in mathematics (Cohen et al., 1994). One longitudinal study 
found a progressive annual decline in math achievement, with reading achievement deficits 
remaining constant, even in pediatric patients with no neuroimaging abnormalities (Wang et al., 
2001). It has been hypothesized that these learning difficulties may be attributed to poor 
sustained attention, organization, and problem-solving skills in both pediatric and adult patients 
(Grattan & Eslinger, 1991). Some of these academic impairments may be buffered in individuals 
from higher socioeconomic status (SES; i.e., social standing of an individual based on access to 
resources) or with parents of higher educational attainment (Brown et al., 1993; Smith, Patterson, 
Szabo, Tarazi, & Barakat, 2013). This may be attributed to factors such adequacy of school 
district funding, familial access to private tutoring, learning materials or environments, educator 
experience level, among other contributors (Aikens & Barbarin, 2008; Bradley, Corwyn, 
McAdoo, & García Coll, 2001; Clotfelter, Ladd, & Vigdor, 2006; Orr, 2003). 
Additional research on academic achievement such as rates of high school graduation and 
completion of higher education in adults with SCD has not been published. Herron, Bacak, King, 
and DeBaun. (2003) completed a brief analysis of high risk (due to frequent pain episodes and 
history of overt stroke) 17-, 18-, and 19-year-olds receiving treatment at St. Louis Children’s 
Hospital and found that only 15% were on target to complete high school. Further research is 
needed to better understand the factors influencing academic achievement in adults with SCD.  
 19 
Attention. Attention refers to a collection of skills, which constitute the ability to 
selectively maintain concentration on salient aspects of an experience while filtering out 
distracters. Difficulties with attention have been noted in children with SCD and history of either 
silent or overt stroke (Brown et al., 1993; Craft, Schatz, Glauser, Lee, & DeBaun, 1993; DeBaun 
et al., 1998; Hijmans et al., 2011); similar to EFs, these difficulties are strongly associated with 
overt stroke in the frontal lobe (Brown et al., 2000; Cohen et al., 1994; Schatz et al., 2001). As 
silent strokes in those with SCD frequently occur in the frontal and parietal lobes, measures of 
attention (and EFs) are commonly included in neuropsychological research for this population. 
DeBaun et al. (1998) found that impaired performance on a measure of sustained attention, the 
Test of Variables of Attention (TOVA), most strongly correlated with the presence of SCI.  
Performance on the TOVA appropriately identified the presence of SCI in 86% of children with 
SCA. In the educational setting, children with SCD often experience deficits with basic sustained 
attention and concentration (Brown et al., 1993). Craft and her colleagues (1993) found 
attentional deficits to be significantly more prominent in SCA pediatric patients when compared 
to both those with diffuse lesions and their healthy sibling controls. 
Research on attention in an adult SCD population is relatively limited; however, 
Vichinsky et al. (2010) also found significant differences between healthy controls and adults 
with SCA without history of neurological insult, on performance on a measure of visual attention 
and scanning, (Test of Everyday Attention [TEA] 2-minute Map Search subtest) as well as the 
TOVA.  
 Executive functions. EFs are a complex set of skills that allow individuals to 
deliberately plan, direct, and monitor their own behavior (Stuss, 1992). The earliest research on 
EFs arose from the study of patients with brain damage, particularly in the frontal lobe (Harlow, 
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1868; Luria, 1972). Phineas Gage is a notable example, as he evidenced difficulty with 
behavioral regulation following a severe workplace accident damaging his orbitofrontal brain 
structures (Harlow, 1868). Through continued research, we have come to understand that EFs are 
primarily orchestrated in the PFC, in coordination with many other brain regions (Alvarez & 
Emory, 2006; Buchsbaum, Greer, Chang, & Berman, 2005; Damasio, Graff-Radford, Eslinger, 
Damasio &  Kassell, 1985; Stuss, 1992; Stuss et al., 1986). One meta-analysis found a moderate 
positive correlation between EFs and both the volume and thickness of the PFC in a healthy adult 
sample (Yuan & Raz, 2014). In addition to reduction in gray matter, the integrity of white matter 
tracts linking the PFC and other regions also influences EF. Brinkman and colleagues (2012) 
found a positive correlation between damage to the white matter of the frontal lobes bilaterally 
and impaired performance on various measures of shifting attention, planning/organization, 
working memory, and cognitive flexibility. Results from these and similar studies, have 
converged to support EFs as orchestrated in the frontal lobe, and most often the PFC specifically. 
A meta-analysis found a significant inverse relationship between WMHs and performance on 
measures of EF (Debette & Markus, 2010). As such, it is reasonable to anticipate deficits in EF 
in patients who both chronically and acutely experience insufficient blood flow to the primary 
orchestrating regions.  
EF is an umbrella term for many distinct yet complementary skills (Miyake et al., 2000). 
In considering the diverse, yet related, nature of EFs, it becomes necessary to identify the 
particular EFs examined in this study. From the larger study on cerebral blood flow in SCD, data 
from several key EFs were available: inhibition (i.e., the ability to inhibit prepotent responses or 
to refrain from an impulsive response in favor of another), working memory (i.e., the ability to 
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mentally hold and manipulate information), and cognitive flexibility (i.e., the ability to switch 
one’s attention between and within tasks).  
Working memory. Working memory refers to the ability to mentally hold and manipulate 
information (Blumenfeld, 2010). The neuroanatomy of working memory remains debated; 
however, it appears to encompass several different brain regions which vary based on the type of 
information processed (Eriksson, Vogel, Lansner, Bergström, & Nyberg, 2015). Barbey, 
Koenigs, & Grafman (2013) studied patients with brain lesion and results indicated that the left 
dorsolateral PFC is primarily implicated in manipulating both verbal and spatial sequencing 
information (e.g., WAIS-III Letter-Number Sequencing subtest, Wechsler Memory Scale - Third 
Edition [WMS-III] Spatial Span Backward subtest) while the right dorsolateral PFC was 
implicated in verbally mediated quantitative reasoning (e.g., WAIS-III Arithmetic subtest)4. 
Meta-analyses have also documented lateralized findings with the left PFC implicated in verbal 
working memory tasks and the right PFC implicated in spatial tasks (Nee et al., 2012; Wager & 
Smith, 2003). In addition to the PFC, the bilateral parietal lobes (right greater than left) play a 
role in spatial working memory and are believed to assist with directing attention (Awh, Vogel, 
& Oh, 2006; Nee et al., 2012). Cerebellar involvement has also been documented, which further 
elucidates the communication that would be necessary in order to integrate these various brain 
regions (Nee et al., 2012). Contributing to this support for working memory as a highly 
collaborative process, disruption to the white matter pathways as part of normal aging has been 
associated with working memory impairment (Charlton, Barrick, Lawes, Markus, & Morris, 
2010). 
 
4 Significant differences were not observed with regard to measures of auditory (WAIS-III Digit 
Span Forward) and visual attention span (WMS-III Spatial Span Forward) suggesting that these 
abilities are mediated by different neuroanatomical processes. 
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Consistent with the complex neuroanatomical networks involved with working memory, 
Baddeley’s model of working memory proposes interdependence of four components: the 
phonological loop, the visuospatial sketchpad, the episodic buffer, and the central executive 
(1996a; 2000; 2003; 2007).  
The phonological loop is responsible for holding speech-based information and operates 
most predominantly in the left hemisphere, especially the temporoparietal region and Broca’s 
area (Paulesu, Frith, & Frackowiak, 1993; Jonides et al., 1998). Unless rehearsed, this 
information will fade within seconds, and increased rehearsal improves the likelihood that the 
information is accurately retained. The presence of the phonological loop is supported by an 
increase in errors for phonetically similar letters and words, as well as denotatively similar 
words, even in stimuli presented visually (Baddeley, 1996a; Conrad, 1964; Conrad & Hull, 
1964).  
The visuospatial sketchpad is the complementary component for visual and spatial 
information (Baddeley, 2007). It operates in much the same way as the phonological loop with 
rehearsal leading to memory storage; however, it is predominantly located in the right 
hemisphere of the brain.  
The episodic buffer integrates information across various sensory inputs including 
phonological, visual, and spatial (Baddeley, 2000). The term episodic is utilized to denote that 
these various pieces of information are integrated into a unitary representation and that for many 
experiences, neither visual/spatial nor phonological data alone are sufficient to encapsulate the 
memory.  
The central executive refers to general processing capacity and is purely attentional, 
incapable of storage (Baddeley, 2007). Baddeley utilizes Norman and Shallice’s model of the 
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Supervisory Attentional System (SAS) to account for the central executive (1986). They propose 
that behavior is controlled at two different levels. On the first are automatic behaviors, which 
occur due to familiar habits. The other, the SAS, is a mechanism for overriding habitual 
behaviors in situations that require it. In the model, individuals with damage to the frontal lobe 
are assumed to also have damage to the SAS. They are able to act in familiar and habitual ways, 
however, lack the ability to appropriately modulate their behaviors to the demands of the context.  
The concept of the phonological loop has been the basis of many evaluations of working 
memory in the pediatric SCD population (e.g., digit span), while the visuospatial sketchpad has 
been less studied. In one study that evaluated both systems, children with SCD demonstrated 
impairment in both verbal and visuospatial working memory (Smith & Schatz, 2016). The same 
study found that although processing speed is decreased in patients with SCD, which limits the 
rate of rehearsal, it does not appear to contribute to the observed deficits in working memory. 
Hijmans and colleagues (2011) found significant deficits in visuospatial working memory, 
although no such differences were found with verbal working memory when comparing a 
pediatric SCD population to healthy SES-matched controls.  
Vichinsky and colleagues (2010) provided the first study on working memory in an adult 
SCA population. They did not include scores for each subtest; however, reported overall 
performance on the WAIS-III Working Memory Index (WMI) to be significantly lower in SCA 
patients without history of neurological insult when compared to demographically matched 
controls (adjusted mean, standard score of 90.75 for patients vs 95.25 for controls [mean 
difference, −4.5]; p = .03). Mackin and colleagues (2014) reported similar results when adjusting 
data from Vichinsky et al. (2010) for intracranial volume (WAIS-III WMI adjusted mean, 
standard score of 91.5 for patients vs 96.0 for controls [mean difference, −4.5]; p = .03). 
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Inhibition. Inhibition, also known as inhibitory control, refers to the ability to resist a 
prepotent response in favor of another (Hampshire, Chamberlain, Monti, Duncan, & Owen, 
2010). The right anterior insula has been implicated in detecting cues to suppress a response 
while the right inferior frontal cortex (also known as the ventrolateral PFC) has been implicated 
as the area of primary activation while enacting the necessary inhibitory control (Aron, Robbins, 
& Poldrack, 2004; Cai, Ryali, Chen, Li, & Menon, 2014; Levy & Wagner, 2011). Performance 
on inhibitory tasks is reduced following prefrontal insults (e.g., overt stroke) in the general 
population (Floden & Stuss, 2006), as well in the pediatric SCD population (Craft et al., 1993; 
Christ, Moinuddin, McKinstry, DeBaun, & White, 2007). Even without apparent medical 
complications, children with SCD show impaired inhibitory control (Hijmans et al., 2011).  
Vichinsky  et al. (2010) provides the only known assessment of inhibition in adults with 
SCA and reports significant differences between neurologically asymptomatic patients and 
healthy demographically matched controls (adjusted mean scaled score of 6.61 for patients vs 
9.06 for controls [mean difference, −2.45]; p < .001) on the Delis–Kaplan Executive Function 
System (D-KEFS) Color Word Interference Task, Trial 35. Studies examining functioning in a 
more general SCD population were not available. 
Cognitive flexibility. Cognitive flexibility refers to the ability to quickly and accurately 
switch between rules or task demands (Dajani & Uddin, 2015). There is support for the primary 
activation of the lateral PFC during tasks of cognitive flexibility (i.e., the Wisconsin Card 
Sorting Test [WCST], D-KEFS; Blumenfeld, 2010; Buchsbaum et al., 2005; Yochim, Baldo, 
Nelson, & Delis, 2007). Functional MRI (fMRI) studies have indicated more specific activation 
of the ventrolateral PFC while participants are performing tasks measuring cognitive flexibility 
 
5 See Methods section for a detailed discussion of this measure. 
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(Dajani & Uddin, 2015). These findings are often reliable enough to differentiate healthy 
controls from patients with frontal lobe lesions (Yochim et al., 2007).  
Cognitive flexibility is comprised of two complementary subsystems: set shifting and 
task shifting (Dajani & Uddin, 2015). Set shifting refers to the ability to process information 
based on different rules within a task whereas task shifting refers to the ability to quickly shift 
between tasks with different instructions (Dajani & Uddin, 2015; Konishi et al., 1998; Monsell, 
2003). Task switching is conceptualized by Bunge and Zelazo (2006) as the most complex form 
of cognitive flexibility. Although distinct concepts, task switching places greater demands on 
one’s capacity for working memory as it requires that the individual remember separate rules for 
each task (Dajani & Uddin, 2015). Aspects of inhibition are also implicated in cognitive 
flexibility as the individual must possess the capacity to control more immediate, or habitual, 
responses in favor of responses that would be consistent with the task demands (Davidson, 
Amso, Anderson, & Diamond, 2006).  
Research on cognitive flexibility in this population is less bountiful than other EFs. 
Watkins and colleagues (1998) found that children with SCD and history of overt stroke had 
significantly more perseverations when administered the WCST when compared to children 
without history of overt stroke and healthy sibling controls. Brown et al. (2000) found that 
children without history of overt stroke worked more quickly on a Trail Making task than did 
children with either SCI or overt stroke history.  
 Adults with SCA and demographically matched controls performed similarly on the WCST; 
however, significant differences were noted based on performance on the D-KEFS Trail Making 
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Test Trial 46 (a test of visual attention, processing speed, and cognitive flexibility; Vichinsky et 
al., 2010). Studies examining functioning in a more general SCD population were not available. 
Sociopolitical Considerations 
Historical Context. As has been the case for other diseases (e.g., syphilis, Tay Sachs), 
research, treatment, and even acknowledgement of the SCD process are all reflective of social 
and political climate. While the African people had long spoken of a debilitating disease marked 
by intense pain episodes (Konotey-Ahulu, 1974), attention in the U.S. focused more on the 
disease’s impact to productivity for slave owners (Phillips, 1999). This occurs alongside the 
development of pseudoscience promoting the fallacy that Black individuals are resistant to pain 
and thus require harsher beatings to gain compliance (Cartwright, 1851). Such behaviors were 
representative of the normative social values of the time.  
A demand for medical parity gained traction during the 1960s and ‘70’s when, civil rights 
advocates brought SCD to the forefront and highlighted the significant health disparities. Indeed, 
SCD became a focus within the civil rights movement. Activists of the time cited the reality that 
most patients with SCA did not live beyond their teenage years (Scott & Castro, 1979; Wailoo, 
2014). Despite the obvious toll on Black health and the disease’s early identification as 
molecular in nature (Herrick, 1910), little research had been conducted to advance treatment for 
these patients. This lack of research contributed to a life expectancy in the teenage years for 
individuals with SCD (Scott & Castro, 1979; Wailoo, 2014); however, the Sickle Cell Anemia 
Control Act of 1972 allocated federal funding toward the research, treatment and education of 
SCD. While critical advancements were made in the years following this action, support soon 
faded (Scott & Castro, 1979). 
 
6 See Methods section for a detailed discussion of this measure. 
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Health Disparities. To this day, individuals with SCD continue to face significant 
disparities with regard to access to quality medical care as well as systemic racism. Despite their 
chronic and debilitating pain, individuals with SCD are often viewed by hospital personnel as 
time-consuming, illegitimate users of health care resources who are seeking prescription drugs 
for illicit purposes (Aisiku et al., 2009; Alao, Westmoreland & Jindal, 2003; Jacob, 2001). These 
perceptions contribute to negative provider attitudes, and ultimately negative healthcare 
experiences for the patient (Carroll, Haywood, & Lanzkron, 2011; Shapiro, Benjamin, Payne, & 
Heidrich, 1997). Although the prevalence of prescription drug abuse is almost doubled in White 
individuals, opioids are more cautiously, more slowly, and less frequently prescribed for Black 
patients (Armstrong, Pegelow, Gonzalez, & Martinez, 1992; Lazio et al., 2010; Vaughn, Nelson, 
Salas-Wright, Qian, & Schootman, 2016). Remnants of Cartwright’s teachings smolder in the 
field as a relatively recent study indicated one-third of physicians and medical students surveyed 
believed that Black patients inherently experience less pain than their White counterparts 
(Hoffman et al., 2016). When seeking emergency medical services, patients with SCD may wait 
25 to 50% longer for treatment when compared to other patients and these results were also 
significantly associated with identification as African American (Haywood, Tanabe, Naik, 
Beach, & Lanzkron, 2013).  
There exists a clear parallel between these modern experiences and the long-standing 
inequity and even cruelty in healthcare for ethnic minorities in the U.S. (Baker et al., 2008; Byrd 
& Clayton, 2001; CDC, 2015; Reverby, 2012; Gamble, 1997). A recent poll conducted by 
National Public Radio (NPR), found that almost one-third of African Americans reported 
experiences of discrimination in a healthcare setting (Neel, 2017). Similar studies have also cited 
significant perceptions of racism when seeking medical treatment (Hatzfeld, Cody-Connor, 
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Whitaker, & Gaston-Johansson, 2008; Nelson & Hackman, 2013; Strickland, Jackson, Gilead, 
McGuire, & Quarles, 2001). African American patients have shared that, among other factors, 
the expectation of racism during health care provision reduces trust in their physician and 
subsequent help-seeking (Benkert, Peters, Clark, & Keves-Foster, 2006; Cuevas & O’Brien, 
2017; Jacobs, Rolle, Ferrans, Whitaker, & Warnecke, 2006; Kennedy, Mathis & Woods, 2007), 
and also contributes to increased subjective stress ratings, depression, and decreased quality of 
sleep (Anderson, 2013; Grandner et al., 2012; Mezuk et al., 2010). Furthermore, this lowered 
trust is associated with nonadherence - a challenge consistently documented in the SCD 
population (Brandow & Panepinto, 2010; Reeves, Tribble, Madden, Freed, & Dombkowski,  
2018; Teach, Lillis, & Grossi, 1998). 
Critique and Need for Further Study 
In comparison to the number of studies completed in the pediatric population, relatively 
little research has focused on adult patients. This may be partially because of SCD’s history as a 
pediatric condition due to the significantly shortened life spans of previous generations. As 
individuals with SCD are now expected to live into their fourth and fifth decades, it is 
increasingly important to expand upon the literature to reflect the needs of those afflicted by the 
condition. Such data are necessary in order to accurately anticipate, prevent, or remediate any 
neuropsychological deficits in this population. 
Further, of those studies that have examined SCD in adults, much of this research has 
rightly focused on understanding the biomedical underpinnings of the disorder (Vichinsky et al., 
2010). As the literature expands, it is also important to balance this increased knowledge by 
examining the relationship between SCD and neuropsychological functioning. Of particular 
importance to the daily functioning of these patients is an examination of the relationship 
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between EFs and SCD in adults. As such, the current study was guided by the following research 
questions and hypotheses: 
Research Questions and Hypotheses 
Consistent with the aforementioned significant group differences between healthy 
controls and SCD patients observed in the pediatric literature, as well as data from the only 
available study examining EFs in an adult SCA population, it is anticipated that analyses of the 
data from the current study will also yield significant group differences on measures of EFs 
when comparing an adult patient sample to healthy controls. The following research question and 
hypotheses are offered: 
 
Research Question: Are there differences in EFs when comparing adults with SCD to a sample 
of healthy controls? 
a. Hypothesis 1a. Patients with SCD will demonstrate significantly lower performance on a 
task of working memory when compared to healthy controls.  
b. Hypothesis 1b. Patients with SCD will demonstrate significantly lower performance on 
an inhibition task when compared to healthy controls.  
c. Hypothesis 1c. Patients with SCD will demonstrate significantly lower performance on a 
task of cognitive flexibility when compared to healthy controls.  
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Chapter 3: Methodology 
Study Aim  
Given previously identified deficits in EFs in children with SCD (Christ et al., 2007; 
Craft et al., 1993; Hijmans et al., 2011), the primary aim of the current study was to examine the 
EFs of working memory, inhibition, and cognitive flexibility in a population of adults with SCD 
in comparison to healthy controls. The following section presents the specific procedures of the 
current study. The research design, sample, recruitment, data collection, and data analyses for the 
study are described. 
Research Design  
This quantitative, pre-experimental study utilized a cross-sectional, static group 
comparison design and is part of a larger project being conducted at Children’s Hospital Los 
Angeles (CHLA) on cerebral blood flow response to perturbations in oxygen tension in 
individuals with and without SCD7. Investigators in the larger study primarily examined: 
1.  Whether resting cerebral blood flow and oxygen are within the normal range in SCD 
patients, 
2. Whether patients with SCD compensate appropriately for brief changes in inhaled 
oxygen tension, and  
3. Whether cerebral blood flow and responses to change in oxygenation correlate with 
neurovascular and brain parenchymal changes on MRI.  
Participants were identified from the CHLA patient population and their family members 
and divided into three groups: those with SCD, those with non-sickle cell anemia, and healthy 
controls. Inclusion criteria consisted of:  
 
7 The primary investigator on this larger study was Dr. John C. Wood. Data collection for the 
study began in 2013.  
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1. At least 13 years of age to cooperate with blood draw and MRI,  
2. Either gender,  
3. Competent to follow instructions,  
4. Informed consent obtained from participants over 18 years of age, or parent/legal 
guardian for those under 18 years of age, 
5. Assent obtained from participants under 18 years of age, and 
6. HbSS, HbSC, or HbSβ0 thalassemia genotypes for those in the SCD group.  
Exclusion criteria included:  
1. Clinically documented prior overt stroke,  
2. Any known illness that might compromise subject safety or data integrity, and  
3. Known pregnancy. 
In addition to a medical workup including MRI and blood draw, the participants 
underwent neuropsychological evaluation to examine profiles of patients with SCD. Consistent 
with the aforementioned areas of identified dysfunction in the SCD population, a standardized 
battery was developed to assess these areas (see Table 1). The neuropsychological assessment 
battery was administered in an outpatient setting by a neuropsychologist or students under her 
supervision. Demographic data (e.g., birth history, education level, income, academic 
achievement, etc.) were collected through a questionnaire as well as review of CHLA medical 
records, if available.  
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Table 1 
Neuropsychological battery for larger study 
Measure Subtests/Trials Acronym Domain 
Wechsler Abbreviated Scale of 
Intelligence - Second Edition 
 WASI-II General Intellectual 
Functioning 
National Institutes of Health Toolbox Pattern Comparison Processing Speed NIH Toolbox 
Processing Speed Wechsler Adult Intelligence Scale – 
Fourth Edition 
Coding, 
Symbol Search WAIS-IV 
Rey Complex Figure Test and 
Recognition Trial 
Copy 
RCFT Visual Motor 
Integration 
California Verbal Learning Test - 
Second Edition & Children’s Version 
 CVLT-II & 
CVLT-C 
Learning & Memory 
Rey Complex Figure Test and Recognition 
Trial 
Immediate, Delay 
RCFT 
Wechsler Adult Intelligence Scale – Fourth 
Edition 
Digit Span Forward 
WAIS-IV Auditory Attention 
Span 
Behavior Rating Inventory of Executive 
Function 
 BRIEF 
Executive Functions 
Delis-Kaplan Executive Function System Color-Word Interference Test, Trail 
Making Test, Verbal Fluency D-KEFS 
National Institutes of Health Toolbox Dimensional Change Card Sort, Flanker 
Inhibitory Control NIH Toolbox 
Wechsler Adult Intelligence Scale – Fourth 
Edition 
Digit Span Backward 
WAIS-IV 
Behavior Assessment System for 
Children - Second Edition 
 BASC-2 Social-Emotional 
PROMIS Fatigue Scale   Health 
Note. that many psychometric measures assess more than one aspect of functioning. As such, 
the primary domain is indicated; however, particular subtests and/or trials are delineated as 
appropriate. The overall measure is bolded the first time it appears in the table. Detailed 
information regarding the measures selected for the current study is discussed in the 
Neuropsychological Protocol and Data Collection section of this paper. 
 
Participants 
The sample for the current study was obtained from data collected as part of the 
aforementioned larger study. As the purpose of the current study was to expand upon the 
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literature for adult patients, a subset of the larger study’s SCD patients were identified for 
inclusion based on their age (18-45 years old). A subset of healthy controls 18- to 45-years of 
age was also selected. Individuals above the age of 45 were excluded to be consistent with the 
general life expectancy of SCD patients and to account for the increased likelihood of cognitive 
changes due to confounding disease processes. (e.g., increased likelihood of CVA/SCI, increased 
rates of both chronic and acute pain). The final sample consisted of 65 individuals (31 SCD and 
34 control). 
Recruitment  
Recruitment and data collection were consistent with an application approved by the 
Institutional Review Board (IRB) of Children’s Hospital Los Angeles (CHLA; IRB 
Application/Protocol #11-00083) as well as the IRB of Pepperdine University Graduate School 
of Education and Psychology, Psychology Division (IRB Application/Protocol #18-12-951). 
Participants were recruited from the CHLA SCD patient population and invitations to participate 
were also extended to their friends and family members. Letters explaining the study and 
requesting both healthy and SCD subjects were either given to patients during their routine 
examinations or mailed to the address in the electronic medical record. Participants were paid a 
total of $200 for 2 days ($100 after completion of the neuropsychological testing and $100 after 
completion of the medical workup which included a brain MRI, oxygen manipulation, and a 
oxygen saturation sensor worn overnight).  
Data Collection 
Neuropsychological Protocol. As part of the larger study, participants completed a 
battery of assessments in the areas of general cognition, attention, language, verbal and non-
verbal learning and memory, processing speed, visuomotor construction, and social-emotional 
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functioning. Given the aims of this study, scores from measures assessing working memory, 
inhibition, and cognitive flexibility were analyzed (see Table 2).  
Table 2 
Neuropsychological trials and subtests analyzed 
Measure Domain 
WASI-II General Cognition 
Measure Trial Executive Function 
WAIS-IV Digit Span (Backward) Working Memory 
D-KEFS Color-Word Interference Test (Trial 3) Inhibition 
D-KEFS Trail Making Test (Trial 4) Cognitive Flexibility 
 
Wechsler Abbreviated Scale of Intelligence – Second Edition (WASI-II). The WASI-II 
is a brief screening measure of general intelligence. It is comprised of four subtests – 
Vocabulary, Similarities, Block Design, and Matrix Reasoning – which are very similar to the 
subtests of the same names on the full-length Wechsler Adult Intelligence Scale – Fourth Edition 
(WAIS-IV) and the Wechsler Intelligence Scale for Children – Fourth Edition (WISC-IV). The 
WASI-II was normed on a sample of 2,300 examinees ranging in age from 6 to 90 years 
including 201 children and 182 adults who were administered both the WASI-II and either the 
WISC-IV or WAIS-IV. General intellectual functioning is estimated as an FSIQ using these 4 
subtests (FSIQ-4) on the WASI-II. Unlike the WAIS-IV, the WASI-II FSIQ-4 does not integrate 
processing speed as a component of intellectual functioning and as a result is less impacted by 
processing speed. For this study, the WASI-II was used to examine group differences with regard 
to general intellectual functioning.  
Wechsler Adult Intelligence Scale – Fourth Edition (WAIS-IV). The WAIS-IV as a 
whole is designed to measure intellectual ability. The test was normed on a sample of 2,200 
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individuals ranging in age from 16 to 90 years. These individuals were stratified by age, gender, 
education level, ethnicity, and region. From the WAIS-IV, our study utilized the Digit Span, 
Coding, and Symbol Search subtests. 
Digit Span. Digit Span has been used widely in research to assess working memory. Digit 
Span is comprised of three trials. During the first trial, the examinee is asked to repeat strings of 
numbers of increasing length. This provides a measure of immediate auditory attention span. 
During the second and third trials, the examinee is asked to repeat strings of numbers of 
increasing length either in reverse order or sequentially (smallest to largest), respectively. Both 
of these trials are measures of working memory, as they require that the examinee not only 
briefly hold this information in mind, but also mentally manipulate the information based on the 
demands of the task. The sequencing task adds the potential confound of number sequencing and 
other cognitive processes, so the Digit Span Backward (DSb) task was selected to provide the 
purest overall measure of working memory. 
Delis-Kaplan Executive Function System (D-KEFS). The D-KEFS is comprised of 9 
stand-alone tests, evaluating various EFs. The D-KEFS was standardized on a sample of 1,700 
individuals, ages 8 to 89 years, who were selected to represent the U.S. population with regard to 
demographic profiles. For this study, the D-KEFS provides data on the EFs of response 
inhibition and cognitive flexibility. More specifically, the Color-Word Interference Test (CW) 
and Trail Making Test (TMT) were selected for this purpose.  
Color-Word Interference Test. To allow for greater differentiation between EFs and other 
confounding variables, CW is comprised of four trials, which are largely modeled after the 
classic Stroop test (Golden, 1978). The first trial requires the examinee to quickly identify the 
color of an organized array of squares and primarily provides a measure of rapid naming. The 
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second trial requires that the examinee quickly read the names of colors printed in black ink and 
primarily provides a measure of word reading speed. The third trial requires that the examinee 
inhibit the automatic response of reading a color name and instead name the color of ink the 
word was printed in (e.g., the word orange printed in purple ink) and primarily provides a 
measure of response inhibition in addition to the above-mentioned foundational skills. 
Performance on this third trial was examined in data analyses. In the final trial, examinees are 
asked to switch between identifying the ink color and reading the name of a color printed in a 
contrasting color, which provides a measure of cognitive flexibility in addition to response 
inhibition, rapid naming, and word reading speed.  
Trail Making Test. Similar to CW, the TMT consists of five trials, which allow for a 
greater degree of discernibility between EFs and other confounds. The first trial screens visual 
scanning ability by asking the examinee to quickly mark only a select number in a large, 
scattered array. The second and third trials evaluate letter and number sequencing, respectively, 
by asking the examinee to sequentially connect either letters or numbers among a field both 
characters. The fourth trial provides an estimate of cognitive flexibility by requiring the 
examinee to quickly alternate or “switch” between connecting numbers and letters in sequential 
order. Performance on this fourth trial was utilized for data analyses as a measure of cognitive 
flexibility. The final trial is a measure of graphomotor speed and asks that the examinee quickly 
connect a series of open circles by tracing along a dashed line as fast as possible while marking 
each circle along the track. 
Preliminary Analysis 
All of the continuous independent, covariate, and dependent variables were examined by 
assessing means, medians, standard deviations, and minimum and maximum scores. The data 
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were examined for the presence of any outliers using the interquartile rule (IQR) with a 2.2 
multiplier (Hoaglin & Iglewicz, 1987). There were no significant outliers found in the data set.   
Categorical variables (i.e., age, gender, race) and ordinal variables (i.e., parental 
educational levels and both childhood and current annual combined family income) were 
examined by assessing frequencies.  
Data Analyses 
SPSS (Version 24) was employed to analyze the data collected. Data analyses included 
descriptive, correlational, and inferential analyses. In order to determine potential significant 
differences in estimated intelligence and demographic factors between SCD and control groups, 
the groups were compared using either independent samples t-tests for continuous variables (i.e., 
age, FSIQ-4) or chi-square tests for categorical variables (i.e., gender, ethnicity, level of parental 
education, income category)8. Given significant group differences related to current annual 
combined family income (described in results), this variable was then incorporated as a covariate 
during subsequent hypothesis testing. More specifically, in order to test hypotheses, a multiple 
analysis of covariance (MANCOVA) was performed with group (SCD or control group) as an 
independent variable, current annual combined family income as a covariate, and performance 
on WAIS-IV DSb (Working Memory), D-KEFS CW Trial 3 (Inhibition), and D-KEFS TMT 
Trial 4 (Cognitive Flexibility) as dependent variables.  
 
 
  
 
8 While parental education and income can be considered continuous variables, the data 
collection method utilized in the original study was based on reporting brackets of educational 
achievement and income that were not equal across levels; therefore, these variables were treated 
as ordinal.  
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Chapter 4: Results 
Description of Participants 
The 65 total participants included 40 females (61.5%) and 25 males (38.5%). Their ages 
ranged from 18 to 45 years (𝒙 ̅ = 28.11) and average intellectual functioning was within normal 
limits (𝒙 ̅ = 95.65; see Table 3 for demographic characteristics of the combined groups). While 
participants were not asked to identify their own race, they were asked to identify each of their 
parents as either African American or Other. The majority of the participants indicated that at 
least one of their parents identified as African American (87.3%).  
Various SES factors were considered. Regarding maternal education level, the majority 
of the sample indicated that their mother completed some college (27.4%), while others reported 
less than 8 years (8.1%), less than 12 years (3.2%), high school (19.4%), associate degree 
(4.8%), bachelor’s degree (17.7%), some graduate school (4.3%), or a graduate degree (14.5%). 
Regarding paternal education level, equal numbers of participants indicated that their father 
completed high school or some college (26.8%), while others reported less than 8 years (3.6%), 
less than 12 years (3.6%), associate degree (3.6%), bachelor’s degree (7.1%), some graduate 
school (5.4%), or a graduate degree (14.3%). The majority of the sample reported a childhood 
annual combined family income of below $20K (35%), while smaller portions of the sample 
indicated incomes of $20K-39K (25%), $40K-59K (22.5%), $60K-79K (12.5%), $80K-99K 
(12.5%), and $100K or above (17.5%). Similarly, the majority of the sample reported a current 
annual combined family income of $20-39K (29.1%), while smaller portions of the sample 
indicated incomes of less than $20K (27.3%), $40-59K (16.4%), $60-79K (9.1%), $80-99K 
(9.1%), and $100K or above (9.1%). 
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Table 3 
Demographic characteristics of the combined groups 
Demographic 𝒙 ̅(SD) 
Age 28.11 (7.84) 
FSIQ-4 95.65 (11.33) 
Demographic N Frequency 
Gender   
Female  40 61.5% 
Male 25 38.5% 
Parent Race   
At least one parent identified as African American 55 87.3% 
Neither parent identified as African American 8 13.7% 
Maternal Education   
Less than 8 years 5 8.1% 
Less than 12 years 2 3.2% 
High school degree 12 19.4% 
Some college 17 27.4% 
Associate degree 3 4.8% 
Bachelor’s degree 11 17.7% 
Some graduate school 3 4.3% 
Graduate degree 9 14.5% 
Paternal Education   
Less than 8 years 2 3.6% 
Less than 12 years 2 3.6% 
High school degree 15 26.8% 
Some college 15 26.8% 
Associate degree 2 3.6% 
Bachelor’s degree 4 7.1% 
Some graduate school 3 5.4% 
Graduate degree 8 14.3% 
Childhood Combined Annual Family Income   
Less than $20,000 14 35% 
(continued) 
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Demographic N Frequency 
$20-39,000 10 25% 
Childhood Combined Annual Family Income   
$40-59,000 9 22.5% 
$60-79,000 5 12.5% 
$80-99,000 5 12.5% 
$100,000 or above 7 17.5% 
Current Combined Annual Family Income   
Less than $20,000 15 27.3% 
$20-39,000 16 29.1% 
$40-59,000 9 16.4% 
$60-79,000 5 9.1% 
$80-99,000 5 9.1% 
$100,000 or above 5 9.1% 
 
Preliminary Descriptive Analyses 
 Data were initially assessed for frequencies (categorical variables), as well as means, 
standard deviations, and minimum and maximum scores (continuous variables). Means and 
standard deviations were computed for continuous variables (see Table 4 for between group 
sample characteristics). There were no outliers identified using the IQR for outliers with a 2.2 
multiplier.  
Demographic Differences and Relationships 
Independent samples t-tests were computed to determine whether there were significant 
group differences with regard to age or FSIQ-4.  
Age. Age was similar between the control (?̅? = 28.74, SD = 8.07) and SCD groups (?̅? = 
27.42, SD = 7.67) and independent samples t-test revealed no significant differences between 
groups with regard to age (t(63) = .67, p = .50). Levene’s Test was utilized to assess the 
assumption of homogeneity of variance and was nonsignificant (F = .02, p = .90). 
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FSIQ-4. Similarly, there were no significant differences with regard to FSIQ-4 between 
the control (?̅? = 96.62, SD = 13.07, p = .47) and SCD groups (?̅? = 94.58, SD = 9.15), t(63) = .72, 
p = .08. Levene’s Test was utilized to assess the assumption of homogeneity of variance and 
results indicated nonsignificant differences in variance (F = 3.25, p = .08).   
Chi square tests were utilized to assess whether there were significant group differences 
with regard to categorical demographic variables (i.e., gender, race, parental education levels, 
and both childhood and current annual combined family income). 
Gender. Binary gender was utilized and coded as either female or male. The control 
group was 61.8% female and 38.2% male while the SCD group was 61.3% female and 38.7% 
male. There were no significant differences between groups with regard to gender, x2 (1, N = 65) 
= .002, p = .97.  
Race. While seven options for race (African American/Black, American Indian/Alaska 
Native, Asian/Pacific Islander, Caucasian, Hispanic/Latino, Multiracial, Other) were included 
within the questionnaire, reported race was then collapsed into two general options during 
analyses for ease of computation and retention of power. Data were coded as either African 
American or Other given the aforementioned overwhelming prevalence of the disease in the 
African American population. Further, data were extrapolated based on the participants’ report of 
their parents’ racial identity such that a participant was categorized as African American if they 
endorsed having at least one parent who is African American (87.3%). Conversely, the 
participant was coded as Other if they endorsed Other for both parents (12.7%)9. There were no 
significant differences between groups with regard to binary race, x2 (1, N = 63) = .38, p = .54.  
 
9 Data were not available for 2 participants. 
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Maternal Education Level. The majority of the control group indicated maternal 
education level of high school (28.1%), while less than 8 years (9.4%), less than 12 years (3.1%), 
some college (25%), bachelor’s degree (15.6%), some graduate school (3.1%), and a graduate 
degree (15.6%) were endorsed to a lesser degree10. The majority of the SCD group indicated 
maternal education level of some college (30%) while less than 8 years (6.7%), less than 12 
years (3.3%), high school (10%), associate degree (10%), bachelor’s degree (20%), some 
graduate school (6.7%), and a graduate degree (15.6%) were endorsed to a lesser degree11. There 
were no significant differences between groups with regard to maternal education level, x2 (7, N 
= 62) = 6.74, p = .46. 
Paternal Education Level. The majority of the control group indicated paternal 
education level of some college (29%), while less than 8 years (16.1%), less than 12 years 
(3.2%), high school (22.6%), bachelor’s degree (9.7%), some graduate school (3.2%), and a 
graduate degree (9.7%) were endorsed to a lesser degree12. The majority of the SCD group 
indicated paternal education level of high school (32%) while less than 8 years (8%), less than 12 
years (4%), some college (24%), bachelor’s degree (20%), some graduate school (6.7%), and a 
graduate degree (13.3%) were endorsed to a lesser degree13. There were no significant 
differences between groups with regard to paternal education level, x2 (7, N = 56) = 5.20, p = .64. 
Childhood Combined Annual Family Income. The majority of those in the control 
group endorsed a childhood annual combined family income of less than $20K (36.7%), while 
$20-39K (16.7%), $40-59K (10%), $60K-79K (13.3%), $80-99K (10%), and $100K and above 
 
10 Data were not available for 2 participants. 
11 A data point was not available for 1 participant. 
12 Data were not available for 3 participants. 
13 Data were not available for 6 participants. 
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(13.3%) were endorsed to a lesser degree14. The majority of those in the SCD group endorsed a 
childhood annual combined family income between $40-59K (30%), while less than $20K (15%) 
$20-39K (25%), $60K-79K (5%), $80-99K (10%), and $100K and above (15%) were endorsed 
to a lesser degree15. However, there were no significant differences between groups overall with 
regard to childhood combined annual family income, x2 (6, N = 65) = 10. 87, p = .09. 
Current Combined Annual Family Income. The majority of control participants 
endorsed a current annual combined family income of between $20-39K (33.3%),16 while the 
majority of those in the SCD group endorsed a current annual combined family income of less  
than $20K (28%; see Figure 
1). Additionally, only one 
participant in the SCD 
group endorsed income 
between $80K-99K (4%),17 
with none endorsing income 
at or above $100K as 
compared to 4 participants 
in the control group endorsing income between $80K-99K (13.3%) and 5 endorsing income at or 
above $100K (16.7%). This resulted in statistically significant differences between groups with 
regard to current combined annual family income, x2 (5, N = 55) = 13.52, p = .02. Therefore, 
these differences were considered during subsequent analyses.  
 
14 Data were not available for 4 participants. 
15 Data were not available for 11 participants. 
16 Data were not available for 9 participants. 
17 A data point was not available for 1 participant. 
 
Figure 1 
Current combined annual family income 
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Table 4 
Between group demographic characteristics 
 Control SCD  
Demographic ?̅? (SD) ?̅? (SD) p  
Age 28.74 (8.1) 27.42 (7.7) .50 
FSIQ-4 96.62 (13.1) 94.58 (9.1) .47 
Demographic N Frequency N Frequency p 
Gender     . 97 
Female  21 61.8% 19 61.3%  
Male 13 38.2% 12 38.7%  
Race     . 54 
At least one parent identified as African American 28 84.8% 27 90%  
Neither parent identified as African American 5 15.2% 3 10%  
Maternal Education     .47 
Less than 8 years 3 9.4% 2 6.7%  
Less than 12 years 1 3.1% 1 3.3%  
High school degree 9 28.1% 3 10%  
Some college 8 25% 9 30%  
Associates degree 0 0% 3 10%  
Bachelor’s degree 5 15.6% 6 20%  
Some graduate school 1 3.1% 2 6.7%  
Graduate degree 5 15.6% 4 13.3%  
Paternal Education     . 64 
Less than 8 years 5 16.1% 2 8%  
Less than 12 years 1 3.2% 1 4%  
High school degree 7 22.6% 8 32%  
Some college 9 29.0% 6 24%  
(Continued) 
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Paternal Education     . 64 
Associate degree 2 6.5% 0 0%  
Bachelor’s degree 3 9.7% 1 4%  
Some graduate school 1 3.2% 2 8%  
Demographic N Frequency N Frequency p 
Childhood Combined Annual Family Income     .09 
$0-19,000 11 36.7% 3 15%  
$20-39,000 5 16.7% 5 25%  
$40-59,000 3 10% 6 30%  
$60-79,000 4 13.3% 1 5%  
$80-99,000 3 10% 2 10%  
$100,000 or above 4 13.3% 3 15%  
Current Combined Annual Family Income     . 02 
$0-19,000 8 26.7% 7 28%  
$20-39,000 10 33.3% 6 24%  
$40-59,000 3 10% 6 24%  
$60-79,000 0 0% 5 20%  
$80-99,000 4 13.3% 1 4%  
$100,000 or above 5 16.7% 0 0%  
 
Testing Assumptions 
 Data were analyzed to ensure all assumptions necessary for MANCOVA. The groups 
are categorical and by definition independent of one another while the dependent variables are 
continuous. Box’s Test of Equality of Covariance Matrices indicated homogeneity of covariance 
(see Table 5). Kolmogorov-Smirnov’s Test of Normality indicated that the data regarding 
working memory, D(61) = .16, p = .001, inhibition, D(61) = .15, p = .002, and cognitive 
flexibility, D(61) = .16, p = .001 were not normally distributed. All three dependent variables 
were transformed into a normal distribution by taking the logarithm with a base of 10 (Bland, 
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Altman, & Rohlf, 2013). Analyses were computed utilizing both the original and transformed 
variables (with the latter using a more cautious p value of .01; Manikandan, 2010). Levene’s Test 
indicated nonsignificant differences in variance for working memory (F = .09, p = .77), 
inhibition (F = .38, p = .54), and cognitive flexibility (F = .16, p = .69). Pearson’s correlation did 
not indicate a statistical relationship between the covariate (current combined annual family 
income) and the dependent variables (working memory, inhibition, cognitive flexibility); 
however, there were moderate positive correlations between the dependent variables themselves 
(see Table 6; Evans, 1996). More specifically, there were moderate positive correlations between 
working memory and inhibition, r = .41, p = .001, working memory and cognitive flexibility, r = 
.47, p < .001, and inhibition and cognitive flexibility, r = .51, p < .001. Tabachnick and Fidell 
(2012) suggest that no correlation be above r = .90; therefore, this assumption has been met. 
Table 5 
Box’s Test of Equality of Covariance Matrices 
Box’s M 6.64 
F 1.03 
df1 6 
df2 16720.03 
Sig. 0.402 
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Table 6 
Pearson correlations for covariate and dependent variables 
Variable 
Current Combined 
Annual Family Income 
Working Memory Inhibition 
r p r p r p 
Current Combined Annual 
Family Income 
 
  
Working Memory -.03 .85   
Inhibition -.06 .65 .41 .001  
Cognitive Flexibility .20 .18 .47 < .001 .51 < .001 
 
Dependent Variables  
 Performance on the measures of EF are reported as scaled scores which have a mean of 
10 and a standard deviation of 3. Broadly average scores range from 7 to 13 with lower scores 
indicating poorer performance and higher scores indicating better performance. Scores have the 
potential to range from 1 to 19.  
Working Memory. The control group performed in the average range with a mean score 
of 10.85, standard deviation of 3.44, and range from 6 to 19 (see Figure 2). Of note, there were 
two individuals in the control group who obtained a scaled score of 19 which placed their 
performance at the 99.9th percentile, one individual who obtained a scaled score of 16 (98th 
percentile), and one individual who obtained a scaled score of 15 (95th percentile.) The SCD 
group also performed in the average range on the measure of working memory with a mean score 
of 10.88, standard deviation of 3.19, and range from 6 to 18. There was one individual in the 
SCD group who obtained a scaled score of 18 (99.6th percentile), one individual who obtained a  
scaled score of 17 (99th percentile), one individual who obtained a scaled score of 16 (98th 
percentile), and one individual who obtained a scaled score of 15 (95th percentile). Despite 
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these above average scores, neither group contained statistically significant outliers. Overall, the 
combined groups performed in the average range with a mean score of 10.86, standard deviation 
of 3.29, and range from 6 to 19. As a result of the aforementioned distribution of scores, the data 
were negatively skewed.  
 
Figure 2 
Working memory scaled score histogram 
 
Inhibition. The control group performed in the average range with a mean score of 
10.44, standard deviation of 2.36, and range from 3 to 13 (see Figure 3). The SCD group also 
performed in the average range on the measure of inhibition with a mean score of 9.71, standard 
deviation of 2.37, and range from 4 to 13. Overall, the combined groups performed in the 
average range with a mean score of 10.10, standard deviation of 2.37, and range from 3 to 13. 
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Figure 3 
Inhibition scaled score histogram 
Cognitive Flexibility. The control group performed in the average range with a mean 
score of 10.44, standard deviation of 2.33, and range from 5 to 14 (see Figure 4). The SCD 
group also performed in the average range on the measure of cognitive flexibility with a mean 
score of 9.46, standard deviation of 2.30, and range from 5 to 13. Overall, the combined groups 
performed in the average range with a mean score of 9.98, standard deviation of 2.35, and range 
from 5 to 14.   
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Hypothesis Testing 
 The aim of the current study was to examine EFs in an adult SCD population in 
comparison to a sample of healthy controls. Hypotheses were tested using a MANCOVA to 
determine statistically significant differences between groups (SCD or control) on each of the 
three EF outcome measures, while controlling for current annual combined family income (see 
Table 7). Additionally, post-hoc analyses were used to also examine potential group differences 
in EFs without controlling for income.  
 Working Memory. The first hypothesis postulated that there would be significant 
group differences on the measure of working memory (hypothesis 1a), with the SCD group 
performing lower than the SCD group. MANCOVA revealed no significant group differences 
 
Figure 4 
Cognitive flexibility scaled score histogram 
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with regard to performance on WAIS-IV DSb when accounting for current annual combined 
family income, F(2, 48) = .20, p = .82, ηp2 = .01. Additionally, no significant group differences 
were found even when current annual combined family income was not accounted for, F(2, 49) = 
.002, p = .82, ηp2 = .008. 
Inhibition. The second research hypothesis was that there would be significant group 
differences on the measure of inhibition (hypothesis 1b), with the SCD group performing lower 
than the SCD group. MANCOVA revealed no significant group differences with regard to 
performance on D-KEFS CW Trial 3 when accounting for current annual combined family 
income, F(2, 48) = .53, p = .60, ηp2 = .02. Additionally, no significant group differences were 
found even when current annual combined family income was not accounted for, F(2, 49) = .68, 
p = .51, ηp2 = .03. 
Cognitive Flexibility. The third hypothesis postulated that there would be significant 
group differences on the measure of cognitive flexibility (hypothesis 1c), with the SCD group 
performing lower than the SCD group. MANCOVA revealed no significant group differences 
with regard to performance on D-KEFS TMT Trial 4 when accounting for current annual 
combined family income, F(2, 48) = 3.04, p = .06, ηp2 = .12. Additionally, no significant group 
differences were found even when current annual combined family income was not accounted 
for, F(2, 49) = 1.98, p = .15, ηp2 = .08. 
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Table 7 
Adjusted and unadjusted means for dependent variables 
  Adjusted Unadjusted 
Domain Subtest ?̅? (SD) ?̅? (SD) 
  Control SCD p Control SCD p 
Working Memory WAIS-IV DSb  10.96 (3.11) 11.19 (3.17) .82 10.85 (3.44) 10.88 (3.20) .99 
Inhibition D-KEFS CW Trial 3  10.71 (2.27) 10.05 (2.20) .60 10.44 (2.36) 9.71 (2.37) .51 
Cognitive Flexibility D-KEFS TMT Trial 4 10.51 (2.29) 9.51 (2.07) .06 10.44 (2.33) 9.46 (2.30) .15 
 
Main Effect. In addition to analyzing group differences for each of the three EF outcome 
measures, MANCOVA was also used to examine associations between the groups and three EF 
outcome measures together. It showed no significant multivariate effect for working memory, 
inhibition, and cognitive flexibility as a whole in relation to whether participants were SCD 
patients or healthy controls, Wilks’ λ = .91, F(3, 46) = 1.52, p = .22, ηp2 = .09. 
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Chapter 5: Discussion 
The purpose of the current study was to examine EF in a sample of adults with SCD. 
More specifically, this study examined the EFs of working memory, inhibition, and cognitive 
flexibility in a patient sample compared to healthy controls. Given the relatively small body of 
literature examining EFs in adults with SCD, this study aimed to contribute to a better 
understanding of the neuropsychological profile of this population. Methodological limitations 
are considered and suggestions for future directions are offered. 
Summary of Results 
 In the current study, both the SCD and control groups performed in the solidly average 
range across measures of EF. Further, there were no significant differences in performance on 
measures of working memory, inhibition, or cognitive flexibility between individuals with SCD 
and healthy controls, both with and without controlling for current combined annual family 
income. Consistent with earlier research (Vichinsky et al., 2010), the SCD group also performed 
within the average range with regard to general intellectual functioning, at approximately 1/3 
standard deviation below the mean, which was not statistically significant when compared to the 
control group, which performed approximately 2 IQ points higher.  
Interpretation of Findings  
 To date, there have been very few studies examining neuropsychological outcomes in 
an adult SCD population. This lapse comes alongside a tremendous increase in the life 
expectancy of those with SCD, such that the group of disorders are no longer considered 
pediatric conditions (Platt et al., 1994). Despite undeniable advancements in life-preserving 
medical treatments, brain-behavior relationships warrant further examination in this population. 
The current study sought to contribute to this need by examining EF in an adult SCD population; 
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however, findings regarding general intellectual functioning are also notable with important 
implications for treatment.  
 Executive Functions. Earlier literature has demonstrated significant differences in EF 
functioning of children with SCD when compared to both healthy controls and normative data 
(Brown et al., 2000; Hijmans et al., 2011; Smith & Schatz, 2016). More specifically, these 
studies indicate that children with SCD function significantly below their typical peers in various 
aspects of EF including working memory and inhibition (with cognitive flexibility being less 
studied). While the deficits are more pronounced in children with history of CVA, they may also 
be present in the absence of CVA, either with or without SCI (Brown et al., 2000).  
Limited literature has documented clinically and statistically significant differences with 
regard to EF when comparing adults with SCA to a sample of healthy controls (Vichinsky et al., 
2010; Mackin et al., 2014). When comparing the participant characteristics of the study 
conducted by Vichinsky and colleagues with the current study, there are some limitations.   
While Vichinsky does not report the mean age of participants, the majority of both patients and 
healthy controls in the study conducted were over the age of 30. In the current study, the average 
age of those in the SCD group was 27.42 years and 28.74 years for those in the control group. 
This suggests a potentially younger cohort in the current study. With regard to sex (binarily 
defined), in Vichinsky’s study, the control group was 63% female as compared to the control 
group which was 49% female. Approximately 61% of participants across either group were 
female in the current study. Due to differences in data collection methods, SES factors are more 
challenging to compare. For example, education levels for the participant were not collected 
(although data was collected regarding parental education level), while Vichinsky reported that 
the majority of the patient sample completed more than a 12th grade education (64%) while 36% 
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obtained less than a 12th grade education, which was similar to that observed in the control group 
(68% vs 32%). All individuals enrolled in Vichinsky’s study self-reported their race as “African 
American,” which is compared to 84.8% of controls and 90% of those in the SCD group in the 
current study. Vichinsky et al (2010) did not provide detailed information regarding treatment 
histories of participants. When administered at least two of the same subtests as were analyzed in 
this current study (D-KEFS CW Trial 3 and TMT Trial 4 which measure inhibition and cognitive 
flexibility, respectively), adults with SCD performed in the low average range, which was 
significantly below their healthy counterparts (Vichinsky et al., 2010). With regard to working 
memory, data were not published on WAIS-III18 DSb performance specifically; however, 
Vichinsky et al. (2010) reported that adults with SCD performed marginally in the broadly 
average range and approximately 1/3 standard deviation below healthy controls on the more 
general WAIS-III WMI. These findings diverge from those obtained in the current study which 
suggest that performance on measures of working memory, inhibition, and cognitive flexibility 
are within the normative range in an adult SCD sample. However, the current sample represents 
the broader SCD population (as compared to SCA specifically) which may account for some of 
the differences in findings. Additionally, participants in the prior study utilized a sample with a 
broader age range than the current study (19-55 vs 18-45 years) and recruitment also occurred 
from 12 sites across the U.S. (rather than the single site recruitment in the current study).  These 
results appear to provide evidence that at least some aspects of EFs may remain intact in adults 
with SCD although understanding of protective factors warrants further research as they may 
reflect site-specific practices or benefits from more recent treatment  protocols.  
 
18 The current study utilized the more recently published WAIS-IV; however, earlier literature 
utilized the WAIS-III.  
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General Intellectual Functioning. With regard to general cognition, earlier studies have 
documented significantly lower functioning in children with SCD when compared to healthy 
controls (Armstrong et al., 1996; Bernaudin et al., 2000; Brown et al., 1993; Schatz et al., 2001; 
Schatz et al., 2002). Typically, those with SCA (as compared to other forms of SCD) present 
with the most pronounced impairment (Berkelhammer et al., 2007; Kawadler et al., 2016; Schatz 
et al., 2002), especially in the presence of CVA although SCI may also have significant 
deleterious effects (Cohen et al., 1994; DeBaun et al., 2012; Hogan et al., 2006). Pediatric SCD 
studies support an inverse relationship between the volume of SCI and IQ - a finding which has 
also been found in non-SCD adult populations (Debette & Markus, 2010; Schatz et al., 2002). 
While the available literature is limited, the relationship between general intellectual functioning 
and SCD come alongside research documenting increased risk of SCI with age (Kassim et al., 
2016). As a significant portion of individuals with SCD will experience stroke of either variety, 
and even in the absence of neuroradiological findings adults with SCD may demonstrate 
performance significantly below a healthy population, concern arises for the neuropsychological 
functioning of the aging SCD population (Farooq & Testai, 2019; Kugler et al., 1993; Ohene-
Frempong et al., 1998) who are more susceptible to stroke in general and as a result are at 
increased risk for cognitive decline. 
While it was not intended as a primary analysis, the current study also contributed 
information toward understanding general cognitive functioning in adults with SCD. Participants 
were initially screened for general intellectual functioning and results indicated that performance 
was within the average range for both the SCD and control groups. Significant group differences 
were not found. A likely explanation for the observed similarities between groups with regard to 
general intellectual functioning relates to the selection of the test battery. Many studies 
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examining neuropsychological functioning utilize measures of FSIQ which is partially comprised 
of processing speed (Armstrong et al., 1996; Bernaudin et al., 2000; Brown et al., 2000; Mackin 
et al., 2014; Vichinsky et al., 2010). The current study measured intellectual functioning utilizing 
the WASI-II FSIQ-4 which provides an estimate based on verbal and nonverbal reasoning, 
without incorporating processing speed. As many cognitive abilities are interdependent, slower 
processing speed may also impact performance in other domains although to a lesser degree 
(e.g., timing out on perceptual reasoning tasks). Slowed processing speed in adults with SCD has 
been documented and there is evidence to suggest that controlling for processing speed accounts 
for SCD versus healthy control group differences with regard to general intellectual functioning 
(Crawford & Jonassaint, 2016). Vichinsky et al. (2010) noted several significant group 
differences when comparing those with SCA to healthy controls (including an adjusted mean 
FSIQ of 92.14 for their SCD group and 96.04 for controls); however, the largest discrepancy was 
with regard to processing speed. As a result of data suggesting processing speed was the greatest 
area of discrepancy between SCA and control groups in the prior study (Vichinsky et al., 2010) 
and research suggesting that significant groups differences are not found with regard to general 
cognition when processing speed is accounted for (Crawford & Jonassaint, 2016), findings 
documenting significant differences may underestimate intellectual functioning. Consistent with 
this notion, Vichinsky et al. (2010) did not find significant group differences with regard to 
verbal or nonverbal reasoning.  
 Treatment Implications. Taken together, these findings indicate that what is known 
regarding the pediatric neuropsychological profile of SCD may not directly apply to adults. The 
understanding of the biological basis of SCD, and in turn, best practices for managing symptoms, 
has developed considerably over the past several decades. Of note, the current study arrives 
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nearly a decade later than the only known study examining EFs in adults with SCA - Vichinsky 
and colleagues’ 2010 publication. It is possible that younger cohorts have been able to benefit 
from earlier implementation of these best practices, which likely influences neuropsychological 
outcomes by reducing the incidence of SCI, CVA, and hypoxia. While explanatory factors 
remain unclear, there are likely treatment implications which are considered below.  
 In 1998, hydroxyurea became the first medication approved by the FDA for the 
treatment of SCD, and at least one limited study has demonstrated improvement in survival 
associated with duration of hydroxyurea use (Ault, 1998; Voskaridou et al., 2010). Along with 
decreasing mortality, hydroxyurea reduces many of the most common complications associated 
with SCD, including need for transfusions to prevent CVA (Voskaridou et al., 2010). 
Hydroxyurea has been effective in reducing the risk of overt stroke in the SCD population and 
strokes of either variety, in turn, have been associated with poorer cognitive functioning (Cohen 
et al., 1994; DeBaun et al., 2012; Hogan et al., 2006; NHLBI, n.d.). Puffer, Schatz, & Roberts 
(2007) more directly examined the relationship between hydroxyurea and cognitive functioning. 
Pediatric patients with SCD who utilized hydroxyurea for at least one year were found to have 
significantly higher general intellectual functioning when compared to those who were not using 
the medication. Recent literature has demonstrated a direct correlation between processing speed 
and loss of white matter integrity (Stotesbury et al., 2018). There is evidence in the pediatric 
SCD literature to suggest that the use of hydroxyurea preserves the integrity of white matter, 
although additional research in an adult population is necessary (Nottage, 2014). Despite these 
benefits, hydroxyurea is underutilized in many settings, and estimates indicate that hydroxyurea 
is only prescribed for less than half of eligible patients (Lanzkron et al., 2008). When prescribed, 
adherence is often poor (Arjunan, Moss, Burns, & De Castro, 2018; Heeney & Ware, 2010). 
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While younger adults are more likely to both understand the purpose of hydroxyurea and report 
use of the medication, this is not true of older individuals who may also benefit (Sinha, Bakshi, 
Ross, & Krishnamurti, 2017). Taken collectively, these findings suggest the cognitive deficits 
documented in previous literature may be prevented through timely and consistent use of 
hydroxyurea. CHLA utilizes early and aggressive hydroxyurea to the maximum tolerated dose 
beginning at 9 months of age, which is consistent with the current guidelines issued by the 
NHLBI. As noted above, these treatment guidelines have not been routinely adopted across 
providers and the treatment protocols utilized at outside institutions, where earlier studies were 
predominantly conducted, is unknown. As the current SCD sample was taken from the CHLA 
patient population, the observed results suggest an early and aggressive treatment protocol likely 
protects against EF deficits. Data regarding length of hydroxyurea use and adherence were not 
collected in the current study which limits our ability to draw conclusions as to whether this 
explanation accounts for the current findings. Additional research should examine relationships 
between use of hydroxyurea, as well as the more recent Endari, and neuropsychological 
functioning. 
Limitations & Future Directions 
Despite best efforts, there are limitations with the current study which should be 
addressed in future research. To be consistent with literature documenting the average life 
expectancy of an individual with SCD, participants in this current study were limited in age 
range from 18 to 45 years. In addition to the health-related needs of the general older adult 
population, individuals with SCD face significant damage to the body organs, tissues, and/or 
bones due to insufficient blood flow (Thein, Igbineweka, & Thein, 2017). Most notably, overt 
stroke remains a leading cause of both morbidity and mortality with recent estimates at 10% the 
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SCD population and 24% of the SCA population experiencing CVA by the age of 45, which is 
approximately three times higher than same-aged African Americans without SCD (Farooq & 
Testai, 2019; Ohene-Frempong et al., 1998; Strouse et al., 2009). The risk of CVA increases 
dramatically with age (with one estimate at 360/100,000 in individuals ages 13-34, 
1,160/100,000 in patients age 35-64, and 4,700/100,000 in individuals age 65 and older; (Kassim 
et al., 2016; Strouse, Jordan, Lanzkron, & Casella, 2009). Additionally, by the fifth decade, 73% 
of patients in a cohort study had at least one form of irreversible organ damage which was 
attributed to vasculopathy (Powars, Chan, Hiti, Ramicone, & Johnson, 2005). As a result of these 
disease-related processes, it is possible that an older sample would yield significant group 
differences. 
Similarly, the current sample excluded patients with a history of CVA to avoid 
confounding the SCD neuropsychological data with results more attributable to CVA itself. In 
addition to CVA, 38% of children with SCD have experienced SCI by the time they reach 
adulthood (Farooq & Testai, 2019). Although SCI may go undetected due to the lack of 
traditional neurological symptoms, significant neuropsychological changes in non-SCD 
populations have been documented (Debette & Markus, 2010). Previous research on SCD 
documenting significant deficits in general intellectual functioning as well as various aspects of 
EF may at least partially reflect slower processing speed as well as disrupted cognitive processes 
reflective of CVA or SCI localization. Additionally, as knowledge regarding the clinical 
management of SCD has grown over recent decades, it is possible that a younger cohort's 
demonstration of cognitive functioning more consistent with healthy peers reflects the benefits of 
newer treatment approaches (such as the early and aggressive use of hydroxyurea to the 
maximum tolerated dose). However, without continued research, results from the current sample 
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may be misleading given the relatively high prevalence of both SCI and overt stroke in the SCD 
population. Further, there is a need to more closely examine the role of SCI on 
neuropsychological functioning in this population utilizing imaging (e.g., MRI) data.  
While this study utilized racial/ethnic data for each participant’s parents, data were not 
coded for the racial/ethnic identity of the participant themselves and as a result participant race 
was determined by whether either parent identified as African American. The vast majority of 
the sample had at least one parent who identified as African American. Given the stated 
disparities in medical care often faced by the SCD population, allowing opportunities for the 
patient to report their own ethnic and/or racial identity preferences may also be an avenue to 
demonstrate provider cultural awareness and interest, which may aid in engaging a population 
with continuing healthcare disparities (Aisiku et al., 2009; Alao et al., 2003; Armstrong et al., 
1992; Lazio et al., 2010; Vaughn et al., 2016).  
The current study did not indicate current income to be contributory with regard to EF, 
and other factors of SES assessed were similar across groups (e.g., parental income, parental 
education level, childhood combined annual income); however, EF has a well-documented 
association with SES (Ardila, Rosselli, Matute, & Guajardo, 2005; Sarsour et al., 2011). As a 
result, future studies should consider controlling for broader aspects of SES (particularly aspects 
present during childhood which have a greater likelihood of interacting with brain maturation 
processes, such as access to an adequate and nutritious diet, availability of books and other 
stimulating developmental materials, or time spent caring for younger siblings outside of school 
hours; Hackman, Gallop, Evans, & Farah, 2015; Lawson, Hook, Hackman, & Farah, 2016). 
Additionally, data regarding parental education levels and income brackets were coded across a 
high number of categories which resulted in many cells with fewer than five participants. As a 
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result, the ability to draw statistical inferences may be limited by the small cell sizes within each 
of these categories. Future studies with larger sample sizes or alternative coding methods may be 
considered.   
Similarly, the current sample was selected from the CHLA patient population and their 
friends and family and, as a result, there may be site-specific confounds. More specifically, by 
selecting participants from an active patient population, there is an inherent bias toward 
individuals with access to healthcare and/or insurance coverage. As discussed above, individuals 
without adequate access to healthcare are more likely to experience complications which may 
make the current sample unrepresentative of those without access to healthcare (Wolfson et al., 
2012). In the absence of routine comprehensive care, adults with SCD may utilize emergency 
services when symptoms become most pronounced without adequate preventative care. Wolfson 
et al., (2012) cited support for this pattern of healthcare utilization as there was a lower 
likelihood of inpatient hospitalization which indicated that needs may be better addressed in a 
less acute setting. Access to, and utilization of, comprehensive care and the relationship to 
neuropsychological functioning should be further evaluated in future studies.  
There are also inherent challenges in evaluating EFs (particularly in medical populations 
who may experience high levels of pain, fatigue, or stress). First, task impurity must be 
considered. By definition, EFs are a network of cognitive skills that rely on one another 
(Baddeley, 1996a; Baddeley, 1996b; Baddeley, 1998; Miyake, Emerson, & Friedman, 2000). 
Given the interconnectivity, many tasks will place demands across EFs, as well as other abilities. 
For example, basic attention, visual processing, motor speed, and numerical awareness have the 
potential to confound results.  
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If EFs are able to be isolated, there remains the question of whether or not the findings of 
standardized assessment are ecologically valid (Barkley & Murphy, 2011). In the clinical setting, 
test administration generally occurs in a quiet, one-to-one, non-distracting room. Seldom does 
this accurately reflect the challenges an individual is likely to face in their natural environments. 
This raises the question of whether performance on these tasks provide meaningful information 
about everyday functioning. Further, prior research indicates that the performance-based 
measures commonly utilized to evaluate EF in the clinical setting (e.g. WCST, Stroop test, 
Tower of London) may not correlate with standardized report of symptoms in other settings, 
suggesting that different constructs may be reflected with each measurement (Toplak, West, & 
Stanovich, 2013). In a clinical setting, performance on measures of EF can be supplemented with 
collateral information (e.g., the BRIEF) for comprehensiveness (Isquit, Roth, & Gioia, 2013). In 
addition to their utility in providing a more wide-ranging account of symptoms, these report-
based measures also provide opportunities to measure aspects of EF that are less amenable to 
performance-based testing (e.g., organization, initiation). 
Despite these limitations, prior research on EFs in adults with SCD has been sparse and 
this study is among the first to examine neuropsychological functioning in an adult SCD sample. 
Additional research is necessary to critically examine whether profiles are similar across 
geographic sites and across patient presentations (e.g., age groups, genotypes, treatment 
histories). Understanding the neuropsychological profile of SCD, including differences in care 
needs for pediatric and adult samples, will allow more informed treatment planning, prevention 
efforts, and remediation as necessary. Further, expanding on this literature provides an 
opportunity to begin to adjust the long-standing history of disparities in medical care often faced 
by African Americans. 
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Appendix A 
Literature Table 
Author(s) Year Title 
Methodology & 
Sample 
Psychometric Measures Outcomes Relevant Findings 
Allen, Anderson, 
Rothman, & Bonner 
2017 
Executive 
functioning and 
health-related quality 
of life in pediatric 
sickle cell disease 
Cross-sectional study 
in which 45 children 
with SCD aged 8 to 
16 years old as well 
as their caregivers 
completed measures 
of quality of life as 
well as executive and 
psychosocial 
functioning. 
Pediatric Quality of Life 
Inventory (PedsQL), 
Behavior Rating 
Inventory of Executive 
Functioning (BRIEF), 
Wechsler Abbreviated 
Scale of Intelligence 
(WASI), Parent 
Experience of Child 
Illness (PECI), Visual 
Analog Pain Scale, 
Hollingshead Two-
Factor Index of 
Socioeconomic Status 
Quality of life 
Controlling for age, pain, and SES, EF was 
found to be positively correlated with child- and 
parent-reported quality of life among children 
with SCD.  
Anie & Green 2005 
Psychological 
complications in 
sickle cell disease 
Literature review 
with a focus on 
psychological coping, 
quality of life, and 
neuropsychology.  
N/A 
Psychological 
complications 
With regard to the neuropsychological profile, 
SCD is associated with impaired verbal 
reasoning, visual-motor integration, attention, 
and EFs which are dependent on location of both 
overt and silent stroke (although to a lesser 
degree in the latter).   
Armstrong Pavlakis, 
Goldman, Thompson, & 
Cuadra 
2010 
Neurocognitive 
function in sickle cell 
disease: Have we 
been missing 
something? 
Editorial N/A Neurocognitive function 
The author provides a very brief and general 
overview of the neurocognitive outcomes for 
those with SCD and calls for action to consider 
the role of SCD related complications when 
evaluating academic and vocational achievement 
(as compared to attributing any impaired 
performance to SES factors). 
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Methodology & 
Sample 
Psychometric Measures Outcomes Relevant Findings 
Baker et al. 2008 
African American 
physicians and 
organized medicine 
1846-1968 
Literature review 
based on the 
American Medical 
Association (AMA)'s 
invitation to a panel 
of experts to review 
and analyze the 
historical roots of the 
black-white divide in 
U.S. medicine. 
N/A 
Segregation, bias, and 
exclusion against African 
American physicians and 
their patients.  
There is a history of discrimination and 
exclusion against Black physicians which 
continues to impact Black physicians and their 
patients. 
Brown et al. 2000 
Neurocognitive 
functioning and 
magnetic resonance 
imaging in children 
with sickle cell 
disease 
Cross-sectional study 
in which 63 children 
and adolescents with 
SCD underwent 
neuropsychological 
assessment after 
referral by 
investigators due to 
concern for learning 
problems and 
adjustment 
difficulties. 
Wechsler Intelligence 
Scale for Children-III 
(WISC-III), Woodcock-
Johnson 
Psychoeducational Test 
Battery: Tests of 
Achievement-Revised 
(WJ-R), Cancellation A's 
Task, Trail Making Test, 
Boston Naming Test, 
Rapid Automized 
Naming (RAN), Purdue 
Pegboard, Child 
Behavior Checklist 
(CBCL), Vineland 
Adaptive Behavior 
Scales 
Neurocognitive function 
Children with history of either overt or silent 
stroke demonstrate differences from their peers 
with regard to attention and EF. These deficits 
are attributed to frontal lobe dysfunction. 
Cahill et al. 2019 
Sickle cell trait and 
cognitive function in 
African Americans: 
The reasons for 
geographic and racial 
differences in stroke 
(REGARDS) cohort 
Longitudinal study in 
which 7,743 Black 
and White 
individuals (583 with 
SCT) with a mean 
age of 63 underwent 
psychological 
assessment.  
Six-Item-Screener (SIS) Neurocognitive function 
Individuals with SCT are more likely to have 
hypertension. In regard to the 
neuropsychological screening, those with SCT 
showed little change over time in word list 
learning and recall, however, processing time 
slowed with age and this affected performance 
on timed tasks. 
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Sample 
Psychometric Measures Outcomes Relevant Findings 
Christ, Moinuddin, 
McKinstry, DeBaun, & 
White 
2007 
Inhibitory control in 
children with frontal 
infarcts related to 
sickle cell disease 
Cross-sectional study 
in which 52 children 
ages 6 to 18 years 
underwent 
neuropsychological 
assessment. Those in 
the clinical group 
were diagnosed with 
SCD. 
Stimulus-response 
reversal inhibitory task 
Inhibitory control 
Children with SCA and frontal infarcts made 
significantly more errors in an inhibitory control 
task than children with SCA without history of 
infarct.   
Crawford & Jonassaint 2016 
Adults with sickle 
cell disease may 
perform cognitive 
tests as well as 
controls when 
processing speed is 
taken into account: A 
preliminary case-
control study 
Cross-sectional study 
in which 31 patients 
with SCD (mean age 
of 33) and 17 
controls (mean age of 
36) underwent 
neuropsychological 
assessment.  
CNS Vital Signs, Stroop 
test and unspecified 
measures of memory, 
finger tapping, symbol 
digit coding, shifting 
attention, and continuous 
performance 
Processing speed 
Results corroborated earlier studies which found 
that there is at least a 10-point deficit in 
processing speed among SCD patients, however, 
when differences in processing speed are 
accounted for, those in the SCD group performed 
as well as controls on various cognitive tasks. 
DeBaun et al.  2012 
Silent cerebral 
infarcts: A review on 
a prevalent and 
progressive cause of 
neurological injury in 
sickle cell anemia 
Literature review N/A Neurological injury 
Risk for silent stroke is greatest in childhood. 
Individuals with overt stroke generally have the 
most impaired cognitive skills, followed by 
individuals with silent stroke, then individuals 
with no stroke history. 
DeBaun et al.  1998 
Cognitive screening 
examinations for 
silent cerebral 
infarcts in sickle cell 
disease 
Cross-sectional study 
in which 28 
individuals with SCD 
ages 7 to 21 years 
underwent 
neuropsychological 
evaluation. 
TOVA, WCST, CVLT-
C 
Attention & EF 
Screening for attention and EF were the most 
reliable in identifying patients with history of 
silent stroke. 
El-Haj & Hoppe 2018 
Newborn screening 
for SCD in the USA 
and Canada 
Literature review N/A Newborn screening 
Newborn screening for SCD has been in place 
across all 50 states since 2006. This has 
improved the prognosis for individuals with 
SCD through timely access to early intervention 
services and prophylactic treatment. The authors 
note that there are few studies that have 
evaluated the long-term health outcomes in 
adults with SCD. 
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Psychometric Measures Outcomes Relevant Findings 
Gaston et al. 1986 
Prophylaxis with oral 
penicillin in children 
with sickle cell 
anemia: A 
randomized trial 
Randomized, double-
blind, placebo-
controlled clinical 
trial examined 
whether 
administration of oral 
penicillin would 
reduce the incidence 
of septicemia in 
children with SCA 
under the age of 3. 
105 children received 
the drug while 110 
children received a 
placebo. 
N/A Septicemia 
Children with SCA have an increased 
susceptibility to bacterial infections. 
Prophylactic oral penicillin was effective in 
reducing the incidence of infection by 84%. The 
authors concluded that those screened for SCD 
during the neonatal period should begin 
prophylactic penicillin by 4 months of age.  
Hijmans et al. 2011 
Neurocognitive 
deficits in children 
with sickle cell 
disease: A 
comprehensive 
profile 
Cross-sectional study 
in which 41 children 
with SCD and 38 
SES-matched 
controls underwent 
neuropsychological 
evaluation. 
WAIS-III, WISC-III, 
Stop task, Tower of 
London, N-back task, 
Beery-Buktenica 
Developmental Test of 
Visual-Motor Integration 
(Beery VMI) 
Neurocognitive function 
SCD was associated with lower IQ scores and 
more than 1 in 3 children with SCD had a FSIQ 
below 75. Deficits were also noted in visuo-
motor functioning and EF.  
Jacobs, Rolle, Ferrans, 
Whitaker, & Warnecke 
2006 
Understanding 
African Americans’ 
views of the 
trustworthiness of 
physicians 
Focus groups were 
conducted at 2 sites 
(a hospital and a 
community advocacy 
organization). 
Participants were all 
African American 
and included 32 
women and 34 men. 
N/A 
African Americans’ 
distrust in healthcare 
Factors contributing to African Americans’ 
distrust in physicians include a lack of 
interpersonal and technical competence, 
perceived quest for profit and expectations of 
racism and experimentation during routine 
provision of health care. Distrust inhibits care-
seeking and may lead to nonadherence.  
Jorgensen et al. 2017 
Disease severity and 
slower psychomotor 
speed in adults with 
sickle cell disease 
Cross-sectional study 
in which 88 adults 
with SCD underwent 
neuropsychological 
screening as well as a 
blood draw.  
Digit Symbol 
Substitution Test 
(DSST)   
Processing speed 
Impairment in psychomotor speed was indicated 
with no significant correlation related to history 
of stroke or severity of anemia. Those with more 
severe genotypes had more slowing than those 
with moderate genotypes. *Note: The authors 
state that there is impairment although the T-
scores are in the average range. 
Kassim et al. 2016 
Silent cerebral 
infarcts and cerebral 
aneurysms are 
prevalent in adults 
with sickle cell 
anemia 
Cross-sectional study 
in which 60 adults 
with SCA underwent 
neuroimaging using 
MRI as well as 
magnetic resonance 
angiography (MRA).  
N/A SCI, aneurysm 
SCI was found in 53% of the participants. Adults 
with SCA also have a higher prevalence of 
cerebral aneurysm than would be expected in 
healthy individuals (9% observed). 
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Kawadler et al.  2016 
Intelligence quotient 
in paediatric sickle 
cell disease: A 
systematic review 
and meta-analysis 
A meta-analysis was 
conducted utilizing 
articles with a 
pediatric SCD 
population, MRI 
information, and a 
Weschler IQ. 
Ultimately, 19 
articles were included 
and compared 3 
groups: stroke vs 
SCI, SCI vs no SCI, 
and no SCI vs 
healthy controls. 
Any Weschler 
intelligence scale (e.g., 
WASI, WISC, or WAIS) 
Full-Scale IQ 
Children with stroke had an IQ of approximately 
10 points lower than those with SCI, those with 
SCI had an IQ approximately 6 points lower than 
those with no SCI, and patients with no SCI had 
an IQ approximately 7 points lower than healthy 
controls. Children with SCD and no apparent 
MRI abnormality have significantly lower IQ 
than healthy controls. 
Kawadler et al. 2015 
White matter damage 
relates to oxygen 
saturation in children 
with sickle cell 
anemia without silent 
cerebral infarcts 
Cross-sectional study 
in which 25 children 
with SCA and 14 
age- and race-
matched controls 
underwent MRI.  
N/A 
White matter 
abnormalities 
There are significant white matter abnormalities 
even in asymptomatic children diagnosed with 
SCA. These abnormalities are taken as evidence 
for the effects of chronic hypoxia on the central 
nervous system. 
Kennedy, Mathis, & 
Woods 
2007 
African Americans 
and their distrust of 
the healthcare 
system: Healthcare 
for diverse 
populations 
Historical perspective 
on African Americas’ 
distrust of the 
healthcare system. 
N/A 
African Americans’ 
distrust in healthcare 
African Americans are often hesitant to 
participate in biomedical research due to 
historically rooted mistrust.  
Kinney et al. 1999 
Silent cerebral 
infarcts in sickle cell 
anemia: A risk factor 
analysis 
Longitudinal study in 
which 42 children 
with SCD and no 
known history of 
CVA underwent 
medical workup. 
N/A SCI 
Children with history of seizures were 15x more 
likely to have SCI. Lower hemoglobin level was 
among other medical factors associated with 
higher rates of SC. Elevated WBC were also 
associated with SCD.  
Mackin et al. 2014 
Neuroimaging 
abnormalities in 
adults with SCA 
Cross-sectional study 
in which 120patients 
with SCA and 33 
healthy controls 
underwent 
neuropsychological 
assessment and 
medical workup. 
WAIS-III 
Neurocognitive function, 
neuroimaging findings 
Individuals with SCA have thinner frontal lobe 
cortex and reduced basal ganglia and thalamus 
volumes compared to healthy controls. Reduced 
volume of the basal ganglia and thalamus were 
significantly associated with lower performance 
IQ, perceptual organization, and working 
memory scores; however, frontal lobe cortex 
thickness was not significantly associated with 
any cognitive measures. 
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Niihara et al. 2018 
A phase 3 trial of L-
glutamine in sickle 
cell disease 
230 patients with 
SCA participated in a 
randomized, placebo-
controlled, double-
blind, phase 3 trial, 
N/A Pain crises 
L-glutamine (brand name Endari) was effective 
in reducing pain crises, acute chest syndrome, 
and hospitalization days. 
Ohene-Frempong et al. 1998 
Cerebrovascular 
accidents in sickle 
cell disease 
Longitudinal study in 
which 4,082 patients 
with SCD were 
followed for an 
average of 5.2 years 
to assess age-related 
prevalence and 
incidence of CVA.   
N/A CVA 
Overall, individuals with SCD have higher rates 
of CVA. More specifically, those with SCA had 
the highest rates followed by other forms of 
SCD.  
Paquin et al.  2019 
Oral morphine 
protocol evaluation 
for the treatment of 
vaso-occlusive crisis 
in paediatric sickle 
cell disease 
Retrospective chart 
review of patients 
with SCD who 
sought medical care 
due to pain crises.  
N/A Hospitalization rate 
The use of oral morphine was effective in 
decreasing the need for hospitalization and 
intravenous medication. 
Paulukonis et al. 2016 
Emergency 
department 
utilization by 
Californians with 
sickle cell disease, 
2005-2014 
Retrospective chart 
review of patients 
with SCD who 
presented to the 
emergency 
department.   
N/A 
Emergency department 
utilization rates 
The study examined emergency department 
utilization in California with SCD. 9/10 patients 
were treated and released during the span of the 
study; The average number of ED visits was 2.1 
visits per year. 
Pegelow et al. 2002 
Longitudinal changes 
in brain magnetic 
resonance imaging 
findings in children 
with sickle cell 
disease 
Longitudinal study in 
which 266 children 
and adolescents with 
SCD underwent 
MRI.  
N/A Neuroimaging findings 
Researchers report that most lesions in girls 
occurred before age 6, whereas boys remained at 
risk until age 10. Overt stroke was less likely to 
be found in the frontal or parietal cortex than 
silent strokes. Children with SCI had an 
increased incidence of new overt stroke and new 
or more extensive silent stroke. 
Rees et al. 2003 
Guidelines for the 
management of the 
acute painful crisis in 
sickle cell disease 
Medline was 
searched via PubMed 
from 1965 to 2001 to 
identify 
hematologists with a 
known interest in 
SCD. They were then 
contacted and invited 
to submit guidelines 
for the management 
of sickle cell pain. 
N/A Pain 
 
Guidelines were established to provide a basic, 
minimum standard of care for patients with SCD 
experiencing pain crises. Suggestions include 
rapid admission to the hospital, analgesics within 
30 minutes of arrival, and ruling out serious 
complications such as infection, acute chest 
syndrome, or neurological events. 
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Routhieaux, Sarcone, & 
Stegenga 
2005 
Neurocognitive 
sequelae of sickle 
cell disease: Current 
issues and future 
directions 
Literature review to 
identify areas for 
future research 
N/A Neurocognitive function 
Overt stroke and SCI are both major 
complications of SCD. Stroke, including silent 
stroke, is associated with decreased IQ, math 
achievement, verbal abilities, and visual-motor 
integration. While the author believes care is 
commonly sought for the physical symptoms of 
SCD, they argue that this is not the case when it 
comes to neurocognitive effects.  
Schatz, Brown, Pascual, 
Hsu, & DeBaun 
2001 
Poor school and 
cognitive functioning 
with silent cerebral 
infarcts and sickle 
cell disease 
Cross-sectional study 
in which 19 children 
with SCA and history 
of SCI, 45 children 
with SWCD and no 
history of SCI, and 
18 healthy sibling 
controls underwent 
neuropsychological 
screening battery as 
well as medical 
workup.  
Boston Naming Test, 
Cancellation of A’s, 
CVLT-C, Differential 
Abilities Scale (DAS), 
Judgment of Line 
Orientation, Rapid 
Automized Naming, 
Peabody Picture 
Vocabulary Test 
(PPVT), Purdue 
Pegboard, TOVA, Trail 
Making Test, Wide 
Range Assessment of 
memory and Learning 
(WRAML), WJ-R, Word 
Fluency 
Neurocognitive function 
Children with SCI had twice the rate of school 
difficulties as children without them. Eighty 
percent of SCI cases had clinically significant 
cognitive deficits, whereas 35% had deficits in 
academic skills. Children with SCI show high 
rates of poor educational attainment, cognitive 
deficits, and frontal lobe injury. Poor school 
performance in SCD is one indicator of SCI. 
Schatz, Finke, Kellett, 
& Kramer 
2002 
Cognitive 
functioning in 
children with sickle 
cell disease: A meta-
analysis 
Meta-analysis of 
studies of cognition 
in SCD to determine 
the size of any 
statistical difference 
between children 
with SCD and 
controls.  
British Abilities Scale 
(BAS), Cancellation of 
Recurring Figures Test, 
DAS, Detroit Test of 
Learning Aptitude-2, 
Goodenough-Harris 
Drawing Test, Kaufman 
Assessment Battery for 
Children (K-ABC), 
Luria Nebraska 
Neuropsychological 
Battery for Children, 
Matching Familiar 
Figures Test, Stanford-
Binet Intelligence Test 
(S-B), VMI, WAIS, 
WCST, WISC, WISC-R, 
WISC-III, WMS 
Neurocognitive function 
 
 
 
 
 
 
Results were small, however, there was a 4.3 
difference in IQ when comparing children with 
SCD to healthy controls. *Note: Analysis 
consolidated various measures of intelligence. 
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Silva et al. 2009 
Brain magnetic 
resonance imaging 
abnormalities in adult 
patients with sickle 
cell disease: 
Correlation with 
transcranial doppler 
findings 
Cross-sectional study 
in which 50 adult 
patients with SCD 
underwent MRI.  
N/A Neuroimaging findings 
MRI abnormalities were noted in 60% of adult 
patients with SCD which is higher than the 
incidence seen in healthy children. 
Smith et al. 2008 
Daily assessment of 
pain in adults with 
sickle cell disease 
Prospective cohort 
study in which 232 
patients with SCD 
age 16 and older 
completed a daily 
pain diary for up to 6 
months. 
N/A Pain 
Pain in patients with SCD is primarily managed 
at home; however, pain episodes should be 
considered the rule rather than the exception. 
Previous studies likely underestimate the 
prevalence of pain in the SCD population.  
Switzer, Hess, Nichols, 
& Adams 
2006 
Pathophysiology and 
treatment of stroke in 
sickle-cell disease: 
present and future 
Literature review of 
the epidemiology, 
clinical spectrum, 
and pathophysiology 
of stroke in SCD to 
identify potential 
therapeutic targets.  
N/A Therapeutic targets 
Overt strokes are associated with occlusion of 
the larger arteries while silent stroke is 
associated with occlusion of the smaller arteries 
and more commonly affect white matter.  
Thogmartin et al 2011 
Sickle cell trait-
associated deaths: A 
case series with a 
review of the 
literature 
Case study and 
literature review of 
16 expired 
individuals with 
SCT.  
N/A Mortality 
An analysis of SCT fatality indicated that despite 
seeking medical treatment, SCT-related micro-
occlusive crisis (often associated with exertion) 
was inadequately considered in the differential 
diagnosis. Several of these cases were associated 
with sudden death.  
Thust, Burke, & 
Siddiqui 
2014 
Neuroimaging 
findings in sickle cell 
disease 
Literature review of 
the neuroradiological 
findings in patients 
with SCD.  
N/A Neuroimaging findings 
Neuroradiological findings in patients with SCD 
are common and are typically, but not always, 
due to vasculopathy. Coexisting acute and 
chronic pathology may pose challenges to 
interpretation. 
van der Land et al.  2016 
Risk factor analysis 
of cerebral white 
matter 
hyperintensities in 
children with sickle 
cell disease 
Cross-sectional study 
in which 40 children 
with SCD underwent 
medical workup 
including MRI.  
N/A Neuroimaging findings 
Several key points were made. Firstly, boys are 
at an increased risk for WMH. Secondly, lower 
HbF was associated with larger WMH volume. 
This suggests that HbF may be protective for 
WMHs and endothelial dysfunction may 
contribute to the development of WMHs by 
reducing cerebral blood flow.   
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Vichinsky et al. 2010 
Neuropsychological 
dysfunction and 
neuroimaging 
abnormalities in 
neurologically intact 
adults with sickle cell 
anemia 
Cross-sectional study 
in which 149 adult 
participants with 
SCA underwent 
neuropsychological 
screening and MRI.  
D-KEFS, TEA, WAIS-
III 
Neurocognitive function, 
Neuroimaging findings 
This study was the first to evaluate 
neuropsychological outcomes in an adult SCD 
population. Although there were no significant 
group differences with regard to total gray matter 
or hippocampal volume, participants with SCD 
demonstrated significantly lower FSIQ and 
processing speed when compared to healthy 
demographically matched controls.  
Wang et al. 2001 
Neuropsychologic 
performance in 
school-aged children 
with sickle cell 
disease: A report 
from the Cooperative 
Study of Sickle Cell 
Disease 
Longitudinal study in 
which 373 children 
with SCD underwent 
neuropsychological 
screening battery as 
well as MRI  
WJ-R, WISC-R, WISC-
III 
Neurocognitive function 
Researchers evaluated neuropsychological 
functioning in a SCD population with history of 
SCI (in the absence of overt stroke). Overall, 
participants with history of SCI demonstrated 
poorer performance than healthy controls on 
various measures. 
Webb & Kwiatkowski 2013 
Stroke in patients 
with sickle cell 
disease 
Literature review 
which discusses the 
current understanding 
of the epidemiology, 
risk factors, and 
pathophysiology of 
small and large 
vessel disease, 
primarily in 
pediatrics. 
N/A Overt stroke 
This article reviews current understanding of the 
epidemiology, risk factors and pathophysiology 
of stroke with a focus on pediatrics. 
Yanamandra et al.  2018 
A case of 
autosplenectomy in 
sickle cell trait 
following an 
exposure to high 
altitude 
Case study of a 24-
year-old man with 
SCT who 
experienced 
autosplenectomy 
following exposure to 
high altitude.  
N/A Autosplenectomy 
 
Individuals with SCT can be asymptomatic until 
exposure to severe hypoxia at which time they 
can manifest clinically with sickle 
cell syndrome. 
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